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iTHE EFFECTS OF CIRCULATING ISO-ANTIBODY ON 
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INTRODUCTION 
One of the major challenges i n biology has been t o 
maintain tissue i n a state of continual growth a f t e r i t 
has been grafted t o another organism. Successful trans-
plantation has been d i f f i c u l t t o achieve i n higher animals 
and at one time, i t appeared u n l i k e l y that these attempts 
would ever be successful. This was not due simply t o 
transplantation, f o r tissue would grow readily when re-
placed i n the o r i g i n a l animal (autotransplantation). Later 
i t was realised t h a t tissue would grow i n other animals, 
providing that they were genetically i d e n t i c a l to the 
donor. I f the tissue was placed i n another member of the 
same species (homotransplantation) or i n a d i f f e r e n t spe-
cies (heterotransplantation), the g r a f t was almost invar-
i a b l y rejected. I t was only a f t e r inbred mouse strains 
had been developed that the genetical basis of transplanta-
t i o n was established (63), (106). 
The homograft reaction leading t o g r a f t r e j e c t i o n i s 
not f u l l y understood (75) though certain features are com-
mon to a l l reactions. The host develops a refractory state 
which persists i n the animal f o r considerable periods of 
time. Further g r a f t s from the same donor are rejected 
more rapidly than the f i r s t and g r a f t s from unrelated 
donors e l i c i t primary forms of..jseigsonse (29), (#7). 
The reaction i s highly specific and bears a l l the 
characteristics of an immune response. Humoral antibody-
appears i n the serum at the time of g r a f t r e j e c t i o n (52) 
and immune host c e l l s are ac t i v e l y produced i n response 
to the tumour (95). I n the past, both of these responses 
have been considered as possible mediators of g r a f t rejec-
t i o n (125), but at present, the prevalent view i s that 
immune c e l l s are solely responsible (£3). 
There i s considerable evidence that immune lymphoid 
tissue contains a l l the immunological properties necessary 
f o r g r a f t r e j e c t i o n (21), (92). Algire and his coworkers 
have shown recently that foreign g r a f t c e l l s could survive 
i n d e f i n i t e l y i n an animal and that g r a f t r e j e c t i o n would 
proceed only when host c e l l s had access t o the g r a f t (121). 
I t w i l l be shown l a t e r that t h i s evidence i s not e n t i r e l y 
convincing, and that the immunological e f f i c i e n c y of the 
host c e l l s may be due to t h e i r producing humoral antibody 
rather than that the c e l l s bear unique q u a l i t i e s . Lymph-
oid c e l l s are known t o produce antibody (3#), (97). 
Humoral antibody can be isolated and studied r e l a -
t i v e l y e a s i l y . I t can be shown that the antibody produced 
i s directed s p e c i f i c a l l y against the antigens of the g r a f t 
tissue and i n many instances, the antibody i s d i r e c t l y 
cytotoxic t o the g r a f t c e l l s i n v i t r o . However, antibody 
alone cannot produce cytotoxic changes (60), and the 
binding of the antibody on t o the c e l l s i s only the i n i -
t i a l step towards the damage of the c e l l s (84). A com-
plex sequence of chemical reactions f o l l o w the binding 
of antibody and these involve accessory humoral and poss-
i b l y c e l l u l a r f a c t o r s . 
The complexity of t h i s reaction may account f o r the 
apparent v a r i a b i l i t y i n the a c t i v i t y of antibody, i n vivo; 
frequently only antibody was added to the system (123). 
I n some instances, antibody appears to have no e f f e c t on 
g r a f t c e l l s (23), (92). Other studies have shown that 
antibody i n h i b i t s the growth of certain tissues i n vivo 
(56). The e f f e c t has been a l i m i t e d one, and there was 
always the p o s s i b i l i t y that host c e l l s had par t i c i p a t e d 
a c t i v e l y i n the r e j e c t i o n . 
I f antibody i s to be considered seriously as a f a c t o r 
i n g r a f t r e j e c t i o n , i t must be shown that antibody i s 
cytotoxic towards the g r a f t c e l l s i n vivo, i n the absence 
of g r a f t c e l l s . This formed the basis of the present 
study. 
The present study followed closely the incidence and 
a c t i v i t y of the antibody produced i n the mouse during the 
active r e j e c t i o n of certain lymphoma c e l l s . I t was hoped 
to establish that isoantibody was produced before there 
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were v i s i b l e signs of g r a f t r e j e c t i o n and to confirm that 
the antibody was cytotoxic t o the tumour c e l l s , i n v i t r o . 
Later, the ef f e c t s of the antibody d i r e c t l y on the 
tumour c e l l s i n vivo were studied. The tumour was grown 
i n i s o l a t i o n , i n Algire d i f f u s i o n chambers, i n the p e r i -
toneal cavity. This prevented contact between g r a f t and 
host c e l l but was no b a r r i e r t o the d i f f u s i o n of antibody. 
Once the incidence and d i s t r i b u t i o n of antibody dur-
ing the r e j e c t i o n of the g r a f t was known and the d i r e c t 
e f f e c t s of antibody on isolated g r a f t c e l l s were deter-
mined, a detailed study was made on the changes occurring 
to the g r a f t c e l l s during t h e i r active r e j e c t i o n i n the 
peritoneum. 
These studies should indicate whether humoral a n t i -
body could p a r t i c i p a t e s i g n i f i c a n t l y i n the destruction 
of c e r t a i n neoplastic c e l l s i n the mouse. 
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A SURVEY OF THE LITERATURE 
Genetics of Transplantation 
Attempts t o tr a n s f e r tumours were made sporadically 
throughout the nineteenth century but the tumours did not 
grow i n the new host. I n 1889, Morau showed that neo-
p l a s t i c tissue could be transferred s e r i a l l y from one 
animal t o another, f o r he maintained a mouse carcinoma 
through seventeen generations (94). I t was not u n t i l 
Beebe and Ewing (1906) showed that they were propagating 
a lineage of l i v i n g c e l l s and not an infectious agent, 
that the concept that tumours were s e r i a l l y transplant-
able gained wide acceptance (19)» (62). 
The successful t r a n s f e r of tumour transplants con-
tinued t o be highly unpredictable. I n some animals a 
tumour would grow continuously, k i l l i n g the hostj i n 
others, the tumour would grow t r a n s i e n t l y and then d i s -
appear, while i n s t i l l others, the tumour would not grow 
at a l l . Jensen, a Danish b i o l o g i s t , t r i e d t o gain some 
ins i g h t i n t o the causes f o r t h i s v a r i a b i l i t y , by defining 
the a c t i v i t y of a series of i n d i v i d u a l tumours (68). He 
transferred one tumour from a white mouse i n t o nearly 
nine hundred white or grey mice, and by using such large 
numbers could show that the grey mice were noticeably 
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more ref r a c t o r y . He suggested that the fa t e of the tumour 
g r a f t was i n some way connected t o the frace' of the host. 
Tyzzer (116) confirmed these findings and Loeb and 
Fleischer concluded that "variations i n s u s c e p t i b i l i t y t o 
inoculated tumours among d i f f e r e n t strains of the same 
species are due t o inh e r i t a b l e causes" ( S i ) . 
To t e s t t h i s hypothesis, animals and tumours would 
have t o be of known and uniform genetic c o n s t i t u t i o n . 
The stocks of mice then held were genetically heterogene-
ous * I t was only a f t e r L i t t l e (73)* Strong (113) and 
Cloudman (37) deliberately i n i t i a t e d inbreeding i n t h e i r 
mouse stocks, t h a t reproducible data on transplantation 
was gained. 
I t was found that tumours a r i s i n g i n an inbred l i n e 
would usually grow i n animals of the same l i n e , but would 
not grow, or showed only temporary growth i n mice of un-
related l i n e s (114). A large number of combinations was 
t r i e d and deliberate crosses were made between inbred 
l i n e s * These resul t s were reviewed by B i t t n e r (25) and 
L i t t l e (79). There was no doubt tha t the success of a 
g r a f t depended upon the presence of certain genes, mutually 
i n g r a f t and host. 
Snell formulated certain •laws 1 of transplantation: 
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" a . A tumour grows progressively i n one hundred per 
cent of the animals on the inbred s t r a i n i n which i t 
originated. 
b. I t f a i l s t o grow, or grows temporarily and then 
regresses i n unrelated s t r a i n s . 
c. I t grows i n one hundred per cent of the f i r s t 
generation (Fl) animals where one parent i s from the 
susceptible s t r a i n . 
d. I t grows i n a f r a c t i o n of second generation (F2) 
or of F l mice crossed t o the resistant parent, the f r a c -
t i o n varying with the stocks and tumours used" (105). 
Snell has made many f u r t h e r contributions t o the 
immunogenetics of transplantation i n mice. By applying 
these laws he has been able to define certain genetic 
relationships between strains precisely and quite con-
s i s t e n t l y . I n 194S, he coined the term "histocompati-
b i l i t y " factors f o r the genes determining tumour a n t i -
g e n i c i t y (105). These hi s t o c o m p a t i b i l i t y genes appear 
t o be in h e r i t e d as dominants and that at least 6 or 7 
l o c i and probably 14 or more l o c i are involved. 
Nevertheless, t h i s work rested upon the assumption 
that the tumour i n i t s transplantation behaviour r e f l e c t e d 
the genetic and antigenic c o n s t i t u t i o n of i t s s t r a i n of 
o r i g i n . 
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The f i r s t d i r e c t evidence f o r t h i s assumption was 
provided by Gorer, when he showed that the serum of an 
animal, that had rejected a tumour, was capable of agglu-
t i n a t i n g red blood c e l l s from the donor s t r a i n (50). 
This implied that tumour tissue and certain normal t i s -
sues shared a common antigen. 
Further experiments showed that i f the antigen was 
found t o be on the red c e l l s of one s t r a i n and not on 
those of a second, i t was possible t o decide the a n t i -
genic type of the back cross and second generation (F2) 
animals. • I f these animals were challenged with tumour 
from the f i r s t s t r a i n , the tumour generally grew only i n 
those mice which had the antigen. The genes determining 
the presence of antigen appeared to be i d e n t i c a l t o those 
determining the f a t e of the g r a f t . Gorer chose to c a l l 
the gene he could define h i s t o c o m p a t i b i l i t y I I (H-2), 
since i t appeared t o coincide with antigen I I previously 
demonstrated i n serum from rabbits immunised against 
mouse blood (51). Subsequently, i t was shown tha t the 
H2 locus was linked to the genes f o r kinky and fused on 
the n i n t h linkage group ( 3 ) . Other H factors were soon 
found,Hi on the f i r s t linkage group (107) and H3 on the 
f i f t h (108). 
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The H-2 antigens are "strong" i n the sense that 
tumours w i l l rarely grow i f there are H-2 differences 
between g r a f t and host. This does not hold true necess-
a r i l y when differences exist between some of the other 
known antigens such as H-l or H-3 (106). 
This serological technique provided a necessary 
independent check on the transplantation method f o r de-
t e c t i n g H genes. I t had certain advantages, not only 
was i t a more dir e c t and less cumbersome technique but 
i t was p o t e n t i a l l y a more delicate i n d i c a t o r of genetic 
v a r i a t i o n . Repeated inject i o n s of tumour i n t o the same 
mice could produce hyperimmune sera containing antibody 
reacting against even quite minor antigens. Gorer and 
Mikulska greatly increased the s e n s i t i v i t y of the t e s t (57). 
I t became apparent that the H-2 'locus' contained a whole 
complex of fact o r s , and the number of h i s t o c o m p a t i b i l i t y 
antigens present i n each mouse s t r a i n was high ( 7 ) . These 
antigens are considered as expressions of co-dominant 
genes i n the sense that both factors are expressed i n the 
heterozygote. 
Isoantigenic differences play a major role i n the 
transplantation process. Tumours which possess the same 
antigens as the re c i p i e n t are accepted and conversely 
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where there i s an antigenic difference between the donor 
and the host, the host reje c t s the tumour. This i s an 
expression of immunity. Woglom (1929) (125) believed 
that tumour immunity was d i f f e r e n t from other immune 
states but t h i s has been disproved (50). Tumours share 
some antigens with other tissues and are rejected i n the 
same way as other tissues or foreign antigenic material (11).. 
The Immune State 
The sequence of events following the i n j e c t i o n of 
foreign neoplastic tissue i n a non-compatible animal i s 
quite c h a r a c t e r i s t i c . There i s a w e l l defined l a t e n t 
period i n which the g r a f t appears healthy and the c e l l s 
grow quite r a p i d l y . A f t e r about f i v e days, i f there i s 
a major H2 antagonism between g r a f t and host, inflammatory 
changes rasy occur around the g r a f t area and the g r a f t c e l l s 
begin t o degenerate. These changes increase i n i n t e n s i t y 
u n t i l a l l the g r a f t c e l l s are k i l l e d ; often the r e j e c t i o n 
i s so rapid that the death of the g r a f t c e l l s i s completed 
i n f o r t y eight hours. This i s followed i n some cases 
with a fibrous encasement of the g r a f t c e l l s . I n a l l 
cases the g r a f t i s eventually resorbed (54). 
Early workers were w e l l aware that the ref r a c t o r y 
state was highly s p e c i f i c and that i t persisted i n the 
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animal f o r a prolonged period of time (125). I n 1903, 
Jensen had noticed than an abortive tumour might make an 
animal immune, f o r a f t e r r e j e c t i o n many animals would not 
support even a temporary growth of the same tumour (68). 
Two years l a t e r , Gaylord and Clowes showed that the immune 
state could be increased by pe r s i s t e n t l y giving the same 
antigenic stimulus t o the animal. A form of vaccination 
was produced (47). I n the same decade, Bashford used 
normal tissues, red c e l l s and e p i t h e l i a l c e l l s , from the 
same animal t o produce immunity against a tumour of the 
same s t r a i n (16). Most of the basic methods f o r evoking 
a state of active immunity were known early i n the century 
even though Gorer's explanations were t h i r t y years away (51). 
The mechanisms e f f e c t i n g immunity were much more d i f -
f i c u l t to assess. During active immunity, one of the most 
obvious changes occurs l o c a l l y i n the area of the g r a f t . 
There i s a marked accumulation of d i f f e r e n t c e l l types at 
d i f f e r e n t stages of the immune response (67) (122) and 
often the c e l l u l a r response varies according t o the na-
ture of the g r a f t (54) (41). Other ch a r a c t e r i s t i c changes 
occur i n organs distant from the g r a f t s i t e , but having 
a vascular or lymphatic connection with the g r a f t bed. 
Frequently there i s considerable hypertrophy of the drain-
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ing lymphnode, of the spleen and of the l i v e r and t h i s 
i s associated with the development of immunity. There 
i s increased a c t i v i t y of the r e t i c u l o e n d o t h e l i a l system 
i n general (20). 
Early workers t r i e d t o establish certain patterns 
of c e l l response that might be related to d i f f e r e n t 
phases of r e j e c t i o n Da Fano detailed some of the chan-
ges that took place a f t e r the sub-cutaneous i n j e c t i o n of 
red c e l l s (39). There was a r i s e i n the number of white 
c e l l s c i r c u l a t i n g i n the blood; at f i r s t these were lympho-
cytes, but by the f o u r t h day, plasma c e l l s and macrophages 
had entered the g r a f t area. 
Murphy (95) and Woglom (125) studied the c e l l re-
sponses to a variety of tissues and agreed essentially 
with Da Fano's claim that the lymphocyte was the main c e l l 
associated with the development and d i s t r i b u t i o n of rejec-
t i o n i Darcy claimed that the plasma c e l l was equally im-
portant (40). Loeb was convinced that the tissue break-
down was due to a s t r i c t l y c e l l u l a r response (80). Though 
he commented that the mere presence of host c e l l s i n a 
breaking down g r a f t was no evidence that they were caus-
a l l y connected with the r e j e c t i o n . 
Loeb emphasised the l i m i t a t i o n of the h i s t o l o g i c a l 
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approach. There i s no doubt that the c e l l u l a r response 
i s v i t a l and that i t i s essential t o i d e n t i f y the c e l l 
types involved, but the significance of the presence of 
a c e l l at any one time cannot be interpreted u n t i l the 
function of each c e l l i s known. 
Haaland f e l t that the refractory state or "immune 
p r i n c i p l e " set i n before the f i r s t tumour was destroyed 
(61). Antibodies often appeared immediately a f t e r g r a f t 
r e j e c t i o n , and i t was tempting to assume that these sub-
stances were causally related t o the state of increased 
resistance. 
I n bacteriology, i t had been known f o r some time 
that immune serum contains an active f a c t o r against the 
i n f e c t i n g organism (9#). By 1897 some of i t s special 
features were known and Durham was w r i t i n g on the "Special 
action of serum of highly immunised animals". The a n t i -
body was highly s p e c i f i c , agglutinating S. ty p h i but not 
E.coli (43). 
Bordet (1S9#) showed that normal tissue could induce 
a s i m i l a r response, f o r red blood c e l l s were agglutinated 
and lysed by the blood of another species previously i n -
jected with that blood (26). Von Dungern produced a 
tissue s p e c i f i c antibody, an e p i t h e l i o l y s i n , by i n j e c t i n g 
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guinea pigs with epithelium from c a t t l e (42K 
Tissue specific antibodies could be produced at w i l l , 
biut- the functional significance of these sera had not 
been proved. Pearce warned that 1 Although such substan-
ces - agglutinins and p r e c i p i t i n s - may be present they 
do not indicate cytotoxic a c t i v i t y 1 (99). 
A more d i r e c t approach towards understanding the 
specific functioning of these antisera was made by Metch-
nikov (89). He produced a spermatoxin by i n j e c t i n g guinea 
pigs with rabbit t e s t i c l e . The immune guinea pig serum 
was inject e d back i n t o rabbits. He could show by d i r e c t 
h i s t o l o g i c a l examination that the testes had ceased t o 
function. 
This approach was a great advance, but h i s t o l o g i c a l 
examination could demonstrate only the extent of the dam-
age, by i t s e l f , i t could not indicate the way i n which the 
changes were produced* 
Lambert and Hanes used new tissue culture techniques 
to show tha t heterologous immune serum i n h i b i t e d the 
growth of c e l l s i n v i t r o (72). Niven confirmed and ex-
tended these observations (96). She was more interested 
i n the detailed c y t o l o g i c a l changes occurring t o the 
g r a f t c e l l s , and the changes i n c e l l permeability accom-
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panying the damage of the c e l l s . She showed that the 
presence of a t h i r d f a c t o r , i n addition t o the c e l l and 
not 
antibody was essential, i f damage and/mere agglutination 
of the c e l l was t o take place. E a r l i e r , Buchner (1389) 
had suggested that a heat l a b i l e serum f a c t o r was necessary 
f o r b a c t e r i o l y s i s (32). Now t h i s t h i r d f a c t o r i s termed 
complement. 
Once the cytotoxic a c t i v i t y of these antibodies had 
been established i n v i t r o , the p o t e n t i a l therapeutic 
value of antibody had to be considered seriously. Pas-
sively t r a n s f e r r i n g antibody t o an animal bearing a 
tumour rare l y had any ef f e c t on the outcome of the tumour 
growth (103^ (see 125)* Indeed, most investigators f a i l e d 
t o f i n d any e f f e c t with antibody and rejected i t s impor-
tance i n the homograft reaction (125). 
The climax came through the persistent e f f o r t s of 
Lumsden (33). Under certain conditions he was able t o 
use antibody t o induce the r e j e c t i o n of a tumour growing 
i n vivo* The conditions were weighted i n favour of the 
antibody. The tumour was recently transplanted i n t o the 
foot region; the antibody was injected l o c a l l y . Attempts 
were made t o maintain the antibody i n the area, e i t h e r 
by c o n s t r i c t i o n of the limb or by l o c a l i n f i l t r a t i o n w i t h 
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adrenalin (#2)i The importance of t h i s outstanding con-
t r i b u t i o n t o the transplantation f i e l d was t o some extent 
marred by Lumsden's own enthusiasm. He was convinced 
that he could produce an antiserum s p e c i f i c a l l y against 
malignant tissue, irrespective of the genotype of the 
donor tissue and host. This claim was not substantiated 
and many people f a i l e d t o accept the significance of his 
e a r l i e r findings (100). 
I n the mid 1930's, Gorer established the antigenic 
relationship between red c e l l s and tumour tissue (51). 
His work centred upon the action of antibody. At f i r s t 
he used i t merely as a t o o l to establish the genetic 
i d e n t i t y of his c e l l s . Later he found th a t the same 
serum i f mixed with tumour would prevent the growth of 
the tumour i n vivo (52). The serum seemed t o act both 
as a haemagglutinin and as a protective antibody. These 
may have been manifestations of the a c t i v i t y of a single 
antibody (5), or the serum may contain two antibodies 
with the same antigenic s p e c i f i c i t y (52). I t i s s t i l l 
not c e r t a i n . 
Gorer's work, then and now, i s the pivot around 
which centres a l l modern th i n k i n g on the a c t i v i t y of 
humoral antibody i n g r a f t r e j e c t i o n (S), (111), (123). 
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He was aware that workers were gaining c o n f l i c t i n g re-
s u l t s with antibody, and the controversy over Lumsden 
was at i t s height. Much of the trouble lay i n the bio-
l o g i c a l v a r i a b i l i t y of the experimental material. Often 
the genetic re l a t i o n s h i p between g r a f t and donor was 
i l l defined. Large s o l i d tissue g r a f t s were used and 
the antibody was of no known a c t i v i t y . I t was l i t t l e 
wonder that the antibody had no e f f e c t (103). Gorer 
used dissociated tumour c e l l s , and assessed the strength 
of his antibody by haemagglutinin t i t r e . Using these 
t o o l s , he devised a series of techniques that would re-
f l e c t the true a c t i v i t y of the antibody. These formed 
the basis f o r subsequent advances. 
Gorer and 01Gorman (59) replaced the old tissue 
culture methods with a simpler method of assaying cyto-
t o x i c a c t i v i t y i n v i t r o . . The c y t o t o x i c i t y test took 
advantage of tumour c e l l s growing i n the dissociated 
ascites form. The death of the i n d i v i d u a l c e l l could be 
followed, f o r the permeability of the c e l l w a l l would 
increase, allowing trypan blue to enter the c e l l r e a d i l y . 
Mouse would not complement i t s own system i n v i t r o but 
Guinea Pig serum was a satisfactory source of complement. 
On the other hand, i n the n e u t r a l i z a t i o n t e s t the 
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antibody was added t o the c e l l i n v i t r o and the actual 
v i a b i l i t y of the population was checked by t r a n s f e r r i n g 
the c e l l s to a susceptible animal (53). Viable c e l l s 
would grow and the time of the appearance of the tumour 
gave some rough i n d i c a t i o n of the number of viable c e l l s 
i n the population. 
I t was possible t o k i l l p r a c t i c a l l y a l l the c e l l s 
of a population w i t h quite small volumes of antibody. 
Indeed, Gorer showed that there was a d e f i n i t e dosage 
rel a t i o n s h i p between the volume of antibody used and the 
number of g r a f t c e l l s affected (56). Burmester confirmed 
t h i s a c t i v i t y i n another species, using fowl leukotic 
c e l l s (33), and Kidd confirmed that other tissues were 
sensitive when he showed that the rabbit Brown Pearce 
carcinoma was k i l l e d with antibody (70). Certain c e l l s 
however, were r e l a t i v e l y less sensitive to antibody. 
Normal rabbit dissociated e p i t h e l i a l c e l l s needed pro-
longed exposure t o antibody before death occurred (24). 
Leukotic c e l l s were p a r t i c u l a r l y vulnerable to 
attack by antibody, but these tests measured the maximum 
po t e n t i a l cytotoxic a c t i v i t y of an antibody, Even i n 
the n e u t r a l i s a t i o n t e s t most of the binding of antibody 
t o the c e l l probably occurred i n v i t r o . Gorer and Amos 
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wanted t o f i n d out whether any cytotoxic e f f e c t s would 
be shown when the tumour and antibody f i r s t met i n 
vivo (56). As a prelude t o the next series of experi-
ments, Amos (5) established that passively transferred 
isoantibodies were stable i n vivo and that they could 
p e r s i s t and bestow protective action f o r several days 
a f t e r the i n j e c t i o n . The antibody was introduced i n t o 
the general c i r c u l a t i o n rather than l o c a l l y i n the g r a f t 
s i t e . 
Gorer and Amos (56) found t h a t they could i n j e c t 
the antibody from seven days before to f o r t y eight hours 
a f t e r the i n j e c t i o n of the tumour c e l l s and obtain com-
plete suppression of growth of the c e l l s . These experi-
ments were performed i n incompatible animals f o r the 
antibody would not be absorbed on to the host tissue; 
thus the antibody C3H a n t i E.L. 4 was injected i n t o C3H 
mice. There were d e f i n i t e l i m i t a t i o n s to the e f f e c t i v e -
ness of these antisera, but i f 0.1 ml. was given twenty 
four hours p r i o r t o the i n j e c t i o n of the tumour c e l l s , 
the growth of up t o two m i l l i o n leukotic c e l l s could be 
prevented. I n the untreated controls, the tumour grew 
progressively t o a palpable size f o r the f i r s t eight 
days. 
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When the c e l l s were grown i n the susceptible s t r a i n , 
say E.L. 4 i n C57B1 the antibody was r e l a t i v e l y less 
e f f e c t i v e , 0.1 ml. would prevent the growth of 500-750 
thousand c e l l s ; w i t h a larger number of c e l l s , the time 
of appearance of the tumour was only delayed, one m i l l i o n 
tumour c e l l s would not appear f o r 10-15 days, but then 
would grow progressively and k i l l the host (56). 
The growth of other leukotic tumours was i n h i b i t e d 
by passively transferred antibody (10). I f other tissues 
were used, p a r t i c u l a r l y those which appear to be r e l a -
t i v e l y insensitive to antibody i n v i t r o from the neutral-
i s a t i o n experiments, the results were equivocal. B i l l i n g -
ham and Brent have used massive doses of antibody of un-
known t i t r e w i t h normal skin homografts and did not 
succeed i n sloughing the g r a f t s (23). Chutna on the 
other hand, claimed to have been successful (35) f (36), 
He used both iso and hetero antibody and injected i t by 
the i n t r a p e r i t o n e a l route. Stetson approached the matter 
cautiously; rather than i n j e c t the antibody systemically 
he has given the antibody l o c a l l y (110), (111), or he 
has used vasodilators l o c a l l y i n the hope of increasing 
the concentration of antibody i n the g r a f t area. With 
both systems he has successfully increased the rate at 
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which g r a f t s were sloughed. 
The experiments with passively transferred antibody 
indicate that antibody i s involved i n the r e j e c t i o n of 
both skin and of tumour, but do not prove th a t the e f f e c t s 
are mediated e n t i r e l y by antibody. I n the experiment of 
Gorer and Amos and especially i n those of Chutna and of 
Stetson and his colleagues, antibody accelerated a reac-
t i o n that would have occurred n a t u r a l l y w i t h i n a few days, 
f o r they used a homologous system which i s inherently 
capable of r e j e c t i n g the g r a f t . Much more convincing 
evidence came from experiments i n which antibody was i n -
jected back i n t o the s t r a i n of mice compatible with the 
tumour. Here the tumour never normally regressed and 
natural immune mechanisms were e n t i r e l y inadequate, yet 
the tumour could be suppressed with isoantibody. 
There are, however, doubts as t o the importance of 
antibody i n the homograft reaction. These come from three 
considerations. Frequently there has been f a i l u r e t o de-
te c t antibody a f t e r the r e j e c t i o n of a g r a f t (115), (117); 
sometimes, i t seems that the timing of the f i r s t appear-
ance of antibody i s too l a t e to account f o r the destruction 
of the g r a f t (93). I n certain circumstances serum was 
unable t o t r a n s f e r the immune state to non-immune animals, 
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whereas minced immune lymphoid tissue from appropriate 
hosts could confer a high degree of immunity (92). 
Specific antibodies can be detected i n the sera of 
animals following the r e j e c t i o n of a g r a f t , providing 
that s u f f i c i e n t l y sensitive techniques are used (12). 
After the primary g r a f t r e j e c t i o n , the antibodies are 
often transient and of low t i t r e (54). Evidence f o r the 
slightness of such a response may be quoted from Gorer, 
of the experiments of Swisher and Young (115). They 
noted that a f t e r a single and a second transfusion of 
red blood c e l l s i n t o a dog that these c e l l s were being 
destroyed at an increasingly rapid rate, but no antibody 
could be detected. I t was only a f t e r the t h i r d trans-
fusion that a po s i t i v e Coombs a n t i g l o b u l i n t e s t was ob-
tained. I n t h i s s i t u a t i o n the bench tests were r e l a t i v e l y 
poor indicators of a b i o l o g i c a l l y active destruction 
mechanism. 
Mitchison and Dube (93) could only detect haeraagglu-
t i n a t i n g antibody at a time appreciably l a t e r than when 
the r e j e c t i o n phase was at i t s height, and they concluded 
that the antibody production was purely a side e f f e c t . 
On the other hand, Gorer, 0'Gorman and Mikulska (58) re-
peated these experiments and showed tha t Mitchison and 
Dubes1 methods of detecting antibody were r e l a t i v e l y 
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i n s e n s i t i v e . The t i t r e s obtained by Gorer were consis-
t e n t l y much higher; f o r example, a negative r e s u l t com-
pared to a t i t r e of 1:1000. Using special methods, Gorer 
could detect antibody of a low t i t r e on the t h i r d day and 
with ease on the f o u r t h day. 
I t would seem l i k e l y that antibody i s produced by 
the animal p r i o r to r e j e c t i o n of the g r a f t , but only the 
haemagglutinating a c t i v i t y of the antibody i s established 
(53). 
More d i r e c t l y related and of weighty importance i n 
transplantation immunity, was the f i n d i n g of Mitchison 
that he could confer a state of apparent immunity on a 
normal mouse, with i n j e c t i o n s of lymphoid tissue from 
an a c t i v e l y immune animal (92). The injected mouse be-
haved as i f i t were immune and of the same s p e c i f i c i t y 
as the ac t i v e l y immune mouse. This was termed a state of 
adoptive immunity. 
They were able to e l i c i t the breakdown of a g r a f t 
of Sarcoma 1 with the i n j e c t i o n of specific immune lymph-
oid tissue and yet f a i l e d t o confer any heightened re sis -
tance against the g r a f t by means of. quite massive amounts 
of hyperimmune serum. 
Experiments of t h i s nature have been repeated i n a 
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number of ways. Winn used dissociated lymph node c e l l s , 
e i t h e r mixed with the tumour or introduced systemically 
(123). There was no doubt that immune c e l l s were r e l a -
t i v e l y superior to serum i n conferring immunity. I n some 
cases there appeared to be an absolute d i s t i n c t i o n . 
This depends upon the nature of the g r a f t . Lymphoid 
c e l l s can be destroyed with passively transferred serum; 
c e l l s s i m i l a r to Sarcoma I appear t o be resistant to a n t i -
body (123). Mitchison was aware of these differences when 
he proposed that g r a f t r e j e c t i o n i s mediated solely by 
c e l l s (92), i n view of his own work on antibody and i t s 
appearance in. g r a f t r e j e c t i o n , He f e l t that antibody was 
probably i r r e l e v a n t . The c e l l s , he thought, may w e l l have 
transferred a bound form of protective antibody resembling 
tha t i n tuberculin s e n s i t i v i t y . Mitchison emphasised the 
s i m i l a r i t y between the homograft response and various 
a l l e r g i c hypersensitive states. E a r l i e r , Burnet and 
Fenner made a s i m i l a r suggestion that perhaps the skin 
homotransplant reaction was essentially a delayed hyper-
s e n s i t i v i t y response (34). 
Amos (8) has recently pointed out that Mitchison»s 
experiments do not define the actual roles of antibody 
and c e l l s , f o r i n using immune lymphoid c e l l s , Mitchison 
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transferred almost as complex a s i t u a t i o n as existed i n 
the immune host. 
I t i s technically extremely d i f f i c u l t t o define the 
c e l l type actually t r a n s f e r r i n g the adoptive immunity. 
On the other hand, i t i s possible to culture single c e l l s 
i n v i t r o and t o show that plasma c e l l s produce humoral 
antibody (97) and there are other techniques t o suggest 
that lymphocytes may produce antibody (3&). These c e l l s 
are c e r t a i n l y carried over i n the lymph node i n adoptive 
transfe r . Lymphoid c e l l s may be washed quite free of 
antibody at the time of tr a n s f e r , but i t i s possible t h a t 
they could resume the production of antibody i n the fresh 
host. I t i s d i f f i c u l t t o say whether the adoptive immu-
n i t y i s produced by humoral or sessile forms of antibody. 
Simi l a r l y i t i s very d i f f i c u l t to. i n t e r p r e t the 
c e l l u l a r reactions occurring around any g r a f t . I t i s 
j u s t these c e l l s , the lymphocytes, plasma c e l l s and h i s -
t i o c y t e s that a c t i v e l y p r o l i f e r a t e around the g r a f t . I t 
i s not known whether some are l i b e r a t i n g high concentra-
tions of antibody l o c a l l y i n the g r a f t bed (53), or 
whether some only produce a sessile form of antibody 
which requires actual c e l l contact before death takes 
place (21). 
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Weaver and his colleagues emphasise the f a c t that 
immune c e l l s are needed f o r the homograft reaction t o 
take place, and that c e l l contact i s perhaps important 
(121). They show dramatic photographs showing immune 
c e l l s and host c e l l s i n contact with each other, with 
both c e l l s dying or dead. Pa r t i c u l a r importance has been 
placed on these results f o r they formed part of a l a r g e r 
inquiry i n which an imaginative new technique was i n t r o -
duced, which, i t seemed, would be able to separate the 
action of host c e l l s from that of humoral antibody i n 
g r a f t r e j e c t i o n (101). 
A l g i r e , Prehn and Weaver devised a porous chamber 
i n which g r a f t c e l l s could be grown i n i s o l a t i o n from 
the host c e l l s , but nourished by the e x t r a - c e l l u l a r f l u i d s 
i n the peritoneum (2). By using membranes of d i f f e r e n t 
pore size, they could manipulate the experimental design 
so that host c e l l s could enter or be excluded from the 
chamber. 
They compared the effe c t s on g r a f t tissue of placing 
the chambers i n immunised and non-immunised animals. 
Chambers containing mouse tissue were placed i n ra t s pre-
viously immunised against mouse. The tissue was destroyed 
irrespective of the pore size of the chamber. This sug-
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gests that humoral hetero-specific antibody alone i s 
quite capable of k i l l i n g the g r a f t tissue. However, 
when they used a mouse homologous s i t u a t i o n , the tissues 
were not k i l l e d unless the pore size was s u f f i c i e n t l y 
large to allow the host c e l l s t o enter (121). 
They thus concluded that c e l l u l a r factors were of 
prime importance i n g r a f t r e j e c t i o n . 
Unfortunately i n certain of the homograft si t u a t i o n s 
used, both g r a f t and host belonged t o the same d a n t i -
genic class ; (H-2d), and thus the immune stimulus would 
be r e l a t i v e l y s l i g h t . , Moreover, no attempt was made by 
these workers t o determine the antibody l e v e l i n the sys-
tem (101). Thus t h e i r i n t e r p r e t a t i o n cannot be e n t i r e l y 
accepted. 
I n summary, although host c e l l s p r o l i f e r a t e and 
invade the g r a f t area during r e j e c t i o n and can readily 
t r a n s f e r immunity, the e f f e c t i v e c e l l s are j u s t those 
which produce or transport antibody (44), (45). The 
g r a f t s i t u a t i o n i n which host c e l l s are present i s com-
plex and the fa c t that antibody i s known to be cytotoxic 
to c e r t a i n g r a f t c e l l s i n v i t r o , makes i t very d i f f i c u l t 
t o i d e n t i f y the factors responsible f o r the r e j e c t i o n of 
the g r a f t . 
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Now that g r a f t c e l l s can be grown i n a simpler 
environment without the contact with host c e l l s , the 
e f f e c t of one possible f a c t o r - antibody on the c e l l s -
can be studied. 
From these studies i t should be possible to deter-
mine whether antibody has any d i r e c t e f f e c t on g r a f t 
c e l l s i f there are no host c e l l s present. I f such an 
eff e c t i s established, the extent and nature of the re-
sponse w i l l be determined together with an understanding 
of the conditions necessary f o r the changes to take 
place. 
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EXPERIMENTAL DESIGN 
Mouse ascites tumour c e l l s were used i n a l l the experi-
ments t o be presented. This type of c e l l i s unique i n t h a t 
i t w i l l grow as a suspension of single c e l l s i n the p e r i t o -
neal cavity (102Q or i n the d i f f u s i o n chamber (13). Single 
c e l l s are more uniformly exposed t o antibody and accessory 
factors than are the c e l l s i n s o l i d transplants. There i s 
no s o l i d stroma and no intimate connection with blood ves-
sels. The tumour c e l l s can be recovered easily without 
damage from manipulation, and the surrounding f l u i d i s 
available i n quantity f o r examination. Ascites lymphomas 
have been studied almost exclusively, since they appear t o 
be very sensitive t o antibody and therefore are w e l l suited 
t o the study of any early changes which r e s u l t i n the death 
of the grafted c e l l s . 
Two techniques have been used. I n the f i r s t , a state 
of active immunity was induced i n the mouse. A counted 
suspension of c e l l s was injected d i r e c t l y i n t o the p e r i -
toneal cavity. The animals were k i l l e d a f t e r a predeter-
mined i n t e r v a l ; the animals were bled and the ascites f l u i d 
removed. The peritoneal cavity was washed out repeatedly 
with large volumes of saline to recover the remaining c e l l s . 
This part of the study wrould give information i n three 
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areas. I t would be p o s s i b l e t o compare the time of appear-
ance of antibody i n the serum w i t h t h a t i n the a c t u a l v i c i n -
i t y of the g r a f t . The t o t a l number of c e l l s i n the peritoneum 
could be determined and by making smears of the exudate, the 
percentage of tumour c e l l s t o host c e l l s could be reasonably 
e s t a b l i s h e d . This p a r t of the study w i l l also show the extent 
of the damage o c c u r r i n g t o the tumour c e l l s , both the percent-
age of c e l l s f u l l y coated w i t h antibody and the c e l l s already 
dead. 
I n the second p a r t of the study, the tumour c e l l s were 
p r o t e c t e d from host c e l l s by p l a c i n g the c e l l s i n d i f f u s i o n 
chambers, and the experiments were designed t o f i n d out i f 
passively t r a n s f e r r e d antibody would produce changes s i m i l a r 
t o those seen i n the f i r s t group. The sampling and a n a l y s i s 
of the c e l l s was e s s e n t i a l l y the same as w i t h the tumour 
grown i n the peritoneum. 
The e f f e c t of antibody on the tumour p o p u l a t i o n could 
be shown i n a number o f ways. Where the antibody r e a c t i o n 
had proceeded t o completion, the a f f e c t e d c e l l s were com-
p l e t e l y l y s e d . The extent of t h i s r e a c t i o n could be gained, 
by comparing the number of i n t a c t c e l l s i n a t r e a t e d popu-
l a t i o n w i t h those i n a c o n t r o l . Those c e l l s which were 
k i l l e d , but not l y s e d , could be detected by adding t r y p a n 
b l u e . F i n a l l y , those c e l l s which had reacted w i t h antibody 
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and had become s e n s i t i z e d , but t o which no overt damage had 
occurred, could be detected by adding an a d d i t i o n a l source 
of complement. 
I n any study on the e f f e c t of antibody on a c e l l popu-
l a t i o n , i t i s e s s e n t i a l t o measure the antibody l e v e l a t t a i n e d 
l o c a l l y . The r e a c t i o n w i l l proceed only i n the presence of 
complement; thus estimates of the l e v e l of f r e e antibody and 
of complement i n the p e r i t o n e a l f l u i d surrounding the chamber 
and i n the chamber i t s e l f have been c a r r i e d out. 
M a t e r i a l s and methods. 
Mouse s t r a i n s (109). 
The mouse s t r a i n s used i n these s t u d i e s possess a high 
degree of genetic u n i f o r m i t y and have been maintained by 
d e l i b e r a t e inbreeding. The DBA/2, C3H and the A/Ha s t r a i n s 
were bred i n the mouse colony of Dr. T. S. Hauschka and the 
DBA/l mice i n the Roswell Park colony. 
DBA/l d i l u t e brown, coat c o l o u r aabbCCdd,histocompatability 
genotype H-2q was o r i g i n a l l y i s o l a t e d by L i t t l e i n 1909 and 
was c a r r i e d by Strong as the D s t r a i n . I t has been known a t 
var i o u s times as the Dbr, dbr, dba and DBA. 
DBA/2 d i l u t e brown, coat colour aabbCCdd, H-2cl. This o r i g i n -
ated from the Dbr stock. 
C3H/St, coat c o l o u r AABBCCDD, H-2k was o r i g i n a l l y i s o l a t e d 
by Strong i n 1920 from the cross Bagg a l b i n o x Dba. 
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A/Ha w h i t e , coat colour aabbccdd, H-2a o r i g i n a l l y i s o l a t e d 
by Strong from the cross Gold Spring Harbor a l b i n o x Bagg 
a l b i n o . 
Tumours. 
The QLl lymphoma arose i n the DBA/1 s t r a i n . The Dalton 
DBA/2 thymoma and the L1210 are both lymphosarcomas a r i s i n g 
i n the DBA/2 s t r a i n . The L#2 lymphoma„originated by Shelton, 
i s grown i n A/Ha mice. The tumours were maintained by the 
weekly t r a n s f e r of c e l l s , by s t e r i l e technique, t o stock 
mice of the s t r a i n i n which the tumour o r i g i n a t e d . 
Antibody. 
The p r o d u c t i o n of i s o antibody. Iso a n t i b o d i e s were pro-
duced by immunizing one s t r a i n w i t h t i s s u e from a second 
s t r a i n . Antibodies of high t i t r e and strong a v i d i t y were 
produced by hyperimmunization. A course of f o u r i n j e c t i o n s 
of antigen ( i n t h i s case tumour t i s s u e ) were given t o the 
hosts over a p e r i o d of two months. The animals were b l e d 
by cardiac puncture t e n days a f t e r the l a s t i n j e c t i o n of the 
anti g e n . Small volumes of the sera were l y o p h y l i z e d and 
stor e d a t -70°C. The a c t i v i t y of the sera was assessed i n 
a number o f ways. 
The d e t e c t i o n of haemagglutinating a n t i b o d i e s . 
The dextran - human serum technique (57) 
Method 
Blood was c o l l e c t e d from the r e t r o - o r b i t a l sinus and 
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was immediately mixed w i t h 3.&% sodium c i t r a t e . The c e l l 
• i i " 
suspension was g e n t l y c e n t r i f u g e d and washed, once i n sodium 
c i t r a t e and once i n a mixture of $0% sodium c i t r a t e and 50% 
s a l i n e . The f i n a l red c e l l suspension was made t o app r o x i -
mately 2.5$ i n a mixture of equal volumes of s a l i n e and 
human serum. This human serum had p r e v i o u s l y been absorbed 
f r e e of any n a t u r a l l y o c c u r r i n g anti-mouse a n t i b o d i e s . 
The antibody was s e r i a l l y d i l u t e d i n 2% Dextran " I n t r a -
dex» i n s a l i n e . 0.025 ml. of the standard c e l l suspension 
was added t o an equal volume of each d i l u t i o n of antibody. 
These tubes, together w i t h c o n t r o l tubes c o n t a i n i n g the red 
c e l l suspension w i t h the 2% Dextran alone, were incubated f o r 
one hour at 37°C The c e l l suspension was streaked on a 
s l i d e . The s t r o n g l y a g g l u t i n a t e d c e l l s could be read by 
eye, but since the a r b i t r a r y s coring sets an 'end p o i n t ' a t 
t h a t a g g l u t i n a t i o n j u s t v i s i b l e t o the naked eye, microscopic 
c o n f i r m a t i o n of the lower values was necessary. 
This technique was a very s e n s i t i v e i n d i c a t o r o f the 
st r e n g t h o f each antibody. Strong a n t i b o d i e s w i t h a known 
t i t r e of 1-4000 ( i . e . a n t i b o d i e s d i l u t e d t o one p a r t i n 4000 
of Dextran g i v i n g an 'end p o i n t ' a g g l u t i n a t i o n ) were needed 
f o r the passive t r a n s f e r s t u d i e s . The technique employed 
had the a b i l i t y t o detect very low concentrations o f a n t i -
body i n c e r t a i n t i s s u e s f l u i d s d u r i n g the homograft r e a c t i o n . 
- 33 -
The d e t e c t i o n of c y t o t o x i c a n t i b o d i e s . 
Amos has shown t h a t c e r t a i n antigens on the red c e l l s 
are shared by white c e l l s , and t h a t these white c e l l s w i l l 
a g g l u t i n a t e i n the presence of s p e c i f i c antibody. Gorer 
has used t h i s observation as the basis of q u i t e a d i f f e r e n t 
technique. I f complement was added t o such an a g g l u t i n a t e d 
suspension, the c e l l s were i r r e v e r s i b l y damaged. 
Method. 
Usually Guinea Pig serum was used as the source of com-
plement. These sera were screened, and only the sera w i t h 
very low c y t o t o x i c a c t i v i t y against mouse c e l l s were used. 
The sera were d i l u t e d t o 66% i n Mammalian Ringer.* Ascites 
tumour c e l l s were c o l l e c t e d i n t o excess Mammalian Ringer 
mixed w e l l and g e n t l y c e n t r i f u g e d . A standard suspension 
of 500,000 c e l l s i n 0.1 ml. Mammalian Ringer was made. 
The antibody was s e r i a l l y d i l u t e d i n Mammalian Ringer 
and 0.025 ml. of both the c e l l suspension and the Guinea Pig 
serum were added t o each volume of antibody. I n d i v i d u a l con-
t r o l s were necessary since the Guinea Pig serum, the a n t i -
body or even the Mammalian Ringer alone may have caused a 
number of the c e l l s t o d i e during the time of i n c u b a t i o n . 
*Composition of Mammalian Ringer 
HaCl 5.2 gram 
KCL 0.2 gram made up w i t h 1000 ml. of t w i c e 
GaCl22H20 0.2 gram d i s t i l l e d water. 
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The t e s t was incubated f o r twenty minutes a t 37°C. 
Occasional a f f e c t e d c e l l s i n a p o p u l a t i o n were com-
p l e t e l y l y s e d and i n some cases t o t a l counts of a l l the 
c e l l s i n the t e s t were made. The great m a j o r i t y of 
a f f e c t e d c e l l s , however, were not lysed; changes i n the 
p e r m e a b i l i t y of the c e l l w a l l took place and t h i s formed 
an adequate measure of the a c t i v i t y of the antibody. 
Usually t h e r e was marked cytoplasmic s w e l l i n g and t h i s 
was accompanied by a l o s s of r i g i d i t y of the c e l l w a l l . 
The c e l l appeared t o collapse on the glass s l i d e , produc-
i n g an increased d e f i n i t i o n of the nuclear membrane. 
This change i n p e r m e a b i l i t y could be seen more e a s i l y 
i f a basic dye such as Trypan Blue was added t o the sus-
pension. Rapid changes i n the c e l l took place; the dye 
was q u i c k l y absorbed by the damaged c e l l , p a r t i c u l a r l y by 
the nucleus. This became swollen, o f t e n causing the outer 
cytoplasmic-membrane t o r u p t u r e . 
Unaffected c e l l s d i d not take up the s t a i n . A c e l l 
suspension o f t e n contained a low percentage of dead c e l l s 
present i n any normal a s c i t e s p o p u l a t i o n . These c e l l s 
were u s u a l l y small and shrunken and though they s t a i n i n -
t e n s e l y w i t h the dye, t h i s was not accompanied by s w e l l i n g 
of the c e l l . 
Assay o f mouse complement. 
Assays of complement u s u a l l y use red c e l l l y s i s as a 
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c r i t e r i o n o f complement a c t i v i t y . I t i s known t h a t the 
l y s i s of red c e l l s r e q u i r e s both antibody and complement 
and t h a t i f the co n c e n t r a t i o n of c e l l s and the d i l u t i o n 
of antibody remain constant, then the degree of l y s i s o f 
the c e l l s i s p r o p o r t i o n a l t o the conc e n t r a t i o n o f comple-
ment present. The c l a s s i c a l complement assay uses a 
r a b b i t anti-sheep haemolysin system and the a c t i v i t i e s 
of complement from a v a r i e t y o f species have been deter-
mined. 
I t was extremely d i f f i c u l t t o detect any complement 
a c t i v i t y i n mouse serum by t h i s method, although t h e r e 
must be complement produced i n the mouse f o r l y s i s of 
c e l l s does occur i n v i v o . I t was f e l t t h a t mouse comple-
ment might complement a mouse l y t i c system r a t h e r more 
adequately. A mouse anti-human haemolysin was produced 
by i n j e c t i n g human group 0 c e l l s i n t o DBA/1 or Ha ICR/Swiss 
mice. Complete l y s i s of human red c e l l s could be achieved 
w i t h t h i s antibody p r o v i d i n g the concentrations of the 
mouse complement were high. 
Method 
Human group 0 red c e l l s were washed tw i c e i n s a l i n e 
and the co n c e n t r a t i o n o f c e l l s adjusted so t h a t i f they 
were completely l y s e d i n a volume o f 1.2 ml. o f d i s t i l l e d 
water, the amount of haemoglobin released could be read 
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on a Coleman spectrophotometer t o give an o p t i c a l d e n s i t y 
of 0.5g at a wave l e n g t h of 415. The serum c o n t a i n i n g the 
mouse a n t i human antibody was heated t o 56°C. t o remove 
the complement present. The antibody was d i l u t e d t o one 
i n f i v e w i t h s a l i n e and added t o an equal volume of the 
red c e l l suspension. These red c e l l s had become f u l l y 
coated w i t h antibody a f t e r they had been incubated f o r 
twenty minutes. The suspension was c e n t r i f u g e d a t 4 ° C , 
the supernatant removed and the c e l l s resuspended i n s a l i n e 
t o t h e i r o r i g i n a l volume. 0.05 ml. o f these c e l l s were 
mixed w i t h 0.05 ml. of the complement d i l u t i o n and incubated 
a t 37°C f o r a f u r t h e r twenty minutes. The contents of 
the tubes were shaken every few minutes dur i n g the incuba-
t i o n p e r i o d . 
The tubes were c e n t r i f u g e d at 400 r.p.m. f o r one min-
u t e . 0.05 ml. of the supernatant was removed, care being 
taken not t o d i s t u r b the p e l l e t of unlysed red c e l l s . 
D i s t i l l e d water was added t o the supernatant t o a volume 
of 1.2 ml. Since i t was known t h a t under these c o n d i t i o n s 
100% l y s i s gave an o p t i c a l density of 0.5$, v a r i a t i o n s i n 
the degree of l y s i s and t h e r e f o r e o f the l e v e l s of com-
plement could be measured i n terms of r e l a t i v e o p t i c a l 
d e n s i t y . 
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Growth of the tumour c e l l s i n the p e r i t o n e a l c a v i t y . 
Sampling procedure. 
I n i t i a l l y , 20 m i l l i o n L1210 or 60 m i l l i o n QL1 tumour 
c e l l s i n 0.2 ml. of Mammalian Ringer were i n j e c t e d i n t o 
the p e r i t o n e a l c a v i t y , care being taken t h a t t here was 
no leakage from the i n j e c t i o n s i t e . Each day, the stage 
of growth of the tumour was assessed. A sample was taken 
both of the a s c i t e s f l u i d and serum f o r the presence of 
antibody. An a l i q u o t of the c e l l s i n the p e r i t o n e a l c a v i t y 
was taken t o estimate the percentage of tumour c e l l s i n the 
p o p u l a t i o n . 
The f o l l o w i n g procedure was adopted: 
The animal was k i l l e d w i t h chloroform and pinned t o 
a small wooden block. A blood sample was taken by cardiac 
puncture. The body w a l l was cut m i d v e n t r a l l y . The p e r i -
toneum was palpated t o mix the c e l l contents. A small 
volume of c e l l s was withdrawn from the p e r i t o n e a l c a v i t y , 
the sample was c e n t r i f u g e d and the a s c i t e s f l u i d removed. 
Part of the sample was mixed w i t h 5$ bovine serum albumin 
and smears of the a s c i t e s c e l l s were made. These were 
st a i n e d w i t h Wright's s t a i n f o r one minute and in.-.a mix-
t u r e of one p a r t s t a i n t o two p a r t s d i s t i l l e d water f o r 
f i f t e e n minutes. 
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Another c e l l sample was taken t o study the v i a b i l i t y 
and the degree of s e n s i t i s a t i o n of the c e l l s . The remain-
i n g c e l l s were placed i n a beaker. The p e r i t o n e a l c a v i t y 
was f l u s h e d f r e e of a l l c e l l s w i t h l a r g e volumes of 
s a l i n e ; 60-100 ml. were used according t o the growth of 
the tumour. The number of c e l l s taken f o r the two sam-
ples was u s u a l l y very small so t h a t a count of the c e l l s 
washed from the peritoneum gave a reasonable estimate o f 
the t o t a l number o f c e l l s growing i n the peritoneum. 
L1210 and QL^ c e l l s migrate from the p e r i t o n e a l cav-
i t y and invade o t h e r t i s s u e s . I n t h i s study, the growth 
of the tumour p o p u l a t i o n i s used merely as an i n d i c a t i o n 
of the development of immunity i n the animal, r a t h e r than 
t o i n d i c a t e the t o t a l number of tumour c e l l s i n the animal. 
Growth of tumour c e l l s i n d i f f u s i o n chambers. 
Construction of the chamber. 
N i t r o c e l l u l o s e f i l t e r s of known pore s i z e were bonded 
t o the upper and lower faces of a s t o u t supporting l u c i t e 
r i n g 16 ram. i n diameter and 5 mm. deep. This completed 
a chamber w i t h an i n t e r n a l volume of 0.3 ml. t h a t could 
be made impermeable t o the passage, of c e l l s . This depend-
ed upon two f a c t o r s : e f f i c i e n t bonding o f the membranes 
t o the l u c i t e by means of a c r i l o i d cement and the pore 
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size of the membrane. The H.A. f i l t e r made by the M i l l i -
pore Corporation has an average pore s i z e of 0.45/**- and 
t h i s has been used throughout the study. The pores were 
l a r g e enough t o a l l o w n u t r i e n t s t o pass i n t o the chamber 
and y e t small enough t o prevent the passage of c e l l s . 
Any major leaks i n the assembly of the chamber were de-
t e c t e d by checking the completed chambers w i t h compressed 
a i r under water. 
A small entry hole was d r i l l e d i n the l u c i t e r i n g . 
This was closed by means of a small tapered l u c i t e peg 
and sealed w i t h a f a s t d r y i n g cement made by d i s s o l v i n g 
M i l l i p o r e f i l t e r i n acetone. The chambers were placed 
• v e r t i c a l l y i n racks i n p e t r i dishes. These and the pegs 
were s t e r i l i s e d overnight i n a 2.5 l i t r e d e s s i c a t o r con-
t a i n i n g 1.9 ml. ethylene oxide. Afterwards the p e t r i 
dishes were allowed t o stand i n a warm atmosphere f o r a t 
l e a s t twenty f o u r hours t o enable the gas t o escape. 
.Experimental chamber procedure. 
The a s c i t e s c e l l suspension was f r e s h l y prepared i n 
Mammalian Ringer and kept on i c e . The i n i t i a l concentra-
t i o n of c e l l s was determined and was kept w i t h i n the range 
of h a l f t o one m i l l i o n c e l l s i n 0.1 ml.; 0.2 ml. a l i q u o t s 
were placed i n each chamber. Great care was taken t o 
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preserve absolute s t e r i l i t y throughout the assembly o f 
the chambers. Contaminating b a c t e r i a grow unchecked i n 
the chambers and k i l l the tumour c e l l s . The c e l l suspen-
sion was mixed c o n t i n u a l l y so t h a t each chamber received 
the same number of c e l l s . This was checked by counting 
the remaining c e l l suspension a f t e r . c o m p l e t i o n of the 
chambers and comparing the count t o the o r i g i n a l . The 
completed chambers were placed i n animals immediately. 
Host mice of known genotype were anaesthetised w i t h 
an intramuscular i n j e c t i o n of sodium p e n t o b a r b i t a l (Nem-
b u t a l , O.S mg. per 1 gm. animal w e i g h t ) . The v e n t r a l 
abdominal w a l l was shaved, swabbed w i t h i o d i n e and a mid-
v e n t r a l i n c i s i o n was made through both the body and p e r i -
t o n e a l w a l l s . A chamber was placed g e n t l y i n t o t he p e r i -
toneum. S t e r i l e Mammalian Ringer was u s u a l l y i n j e c t e d 
i n t o the peritoneum t o bathe the chamber, and the p e r i t o -
neal w a l l was sewn w i t h a running suture of Ethicon nylon. 
The body w a l l was u s u a l l y closed w i t h 11 mm. Michel c l i p s 
although i t was found t h a t where l a r g e volumes of f l u i d 
were t o be i n j e c t e d two or three days a f t e r t h i s o p e r a t i o n , 
a t i g h t suture w i t h nylon was needed t o ensure no leakage 
of the i n j e c t e d f l u i d s through the wound. 
Sampling of the chamber. 
The chamber was removed from the peritoneum and t h e 
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outside c a r e f u l l y swabbed f r e e o f c e l l s . The chamber was 
he l d so t h a t one f i l t e r could be s l i t upwards t o form a 
l i d and the f l u i d was removed w i t h a sy r i n g e . Usually a 
f i b r o u s c l o t remained i n the chamber; t h i s was placed 
separately i n a tube so t h a t the i n t e r i o r of the chamber 
could be r i n s e d f r e e of c e l l s . C e l l s tend t o grow i n the 
c l o t and so i t was important t o t i t r u r a t e the c l o t i n 
excess Mammalian Ringer. A l l the washings were pooled 
and a t o t a l c e l l count made. H i s t o l o g i c a l sections 
showed t h a t r e l a t i v e l y few c e l l s remained i n the c l o t . 
The t o t a l c e l l counts gained i n t h i s way are probably 
plus or minus 5% of the a c t u a l p o p u l a t i o n i n the chamber. 
This inaccuracy does not i n t e r f e r e w i t h the i n t e r p r e t a t i o n s 
of the r e s u l t s and i s c e r t a i n l y no l e s s accurate than the 
technique described e a r l i e r - t h a t of washing c e l l s out 
of the p e r i t o n e a l c a v i t y . 
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RESULTS 
PART I . EVIDENCE FOR THE APPEARANCE OF ANTIBODY DURING 
THE HOMOGRAFT REACTION 
Three tumour host combinations were used: QL^ c e l l s 
were grown i n C3H mice; L1210 c e l l s were grown i n DBA/l 
and C3H mice. Nine separate experiments were undertaken 
i n which a standard dose of tumour c e l l s were i n j e c t e d 
i n i t i a l l y i n t o the peritoneum. The growth of the tumour 
c e l l s was checked every 24 hours throughout the homograft 
r e a c t i o n . The L1210 and QL^ tumours have very s i m i l a r 
growth curves. Thus, Graph 1 represents the composite 
f i n d i n g s of the nine experiments, so t h a t the general 
f e a t u r e s of the r e a c t i o n s are shown, 
1. Growth of the tumour c e l l s i n the peritoneum. 
The tumour grew r a p i d l y i n the peritoneum and 
f l u i d accumulated u n t i l Day 6. At t h i s time the animals 
were g r e a t l y distended and the volumes of a s c i t e s f l u i d 
o f t e n exceeded 2 ml. By Day 7, there was a dec l i n e i n 
the tumour p o p u l a t i o n . This d e c l i n e continued r a p i d l y 
through Day 8, and by Day 9 there were p r a c t i c a l l y no 
tumour c e l l s remaining i n the p e r i t o n e a l c a v i t y . 
I f the r e s u l t s of two i n d i v i d u a l experiments are 
stu d i e d - Graph 2 and 2a - i t w i l l be seen t h a t although 
the c e l l counts were reasonably s i m i l a r i n the a c t i v e growth 
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phase of the tumour, Day 5 and Day 6, there were f l u c t u a -
tions i n the c e l l count on the seventh day. This would 
appear to be a r e f l e c t i o n of the s l i g h t l y different timing 
of r e j e c t i o n i n the individual animals. Rejection of L1210 
seemed at a height on Day 7 i n C3H and DBA/l hosts. By the 
eighth day, there were few tumour c e l l s i n any of the animals. 
2. The appearance of haemagglutinins., 
Both the serum and a s c i t e s f l u i d were tested 
on the day of sampling against red c e l l s of the appropriate 
genotype. I t w i l l be seen from Graph 1 that there was a 
trace of antibody i n the serum on Day 4 and on Day 5. 
The antibody had increased i n t i t r e by Day 6. From Graph 
1 i t appeared that there was a drop i n the strength of 
the c i r c u l a t i n g antibody on the seventh day. Afterwards, 
the t i t r e of the antibody rose continually u n t i l Day 9, 
when i t reached a plateau. 
There was some varia t i o n i n the l e v e l of antibody 
found i n the serum of animals sampled on the same day 
(Graph 2 and 2a). This was p a r t i c u l a r l y marked on Day 7 
when the r e j e c t i o n of the tumour was at i t s height. I t 
appeared that the animals with a higher t i t r e of free 
antibody were i n a more advanced stage of r e j e c t i o n . 
There was no detectable antibody found i n the p e r i -
toneum u n t i l the r e j e c t i o n of the graft was almost com-
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pleted and there were few tumour c e l l s remaining i n the 
peritoneum (Table 1 ) . Later the antibody t i t r e rose 
sharply (Graph 1 ) . At t h i s stage the f l u i d i n the p e r i -
toneum was rapidly disappearing, and i t was t e c h n i c a l l y 
d i f f i c u l t to check whether the t i t r e of the antibody rose 
continuously and approached the l e v e l i n the serum. 
3. The appearance of cytotoxic antibody. 
Although the presence of antibody could be 
shown by agglutination, t h i s form of a c t i v i t y has l i t t l e 
d i r e c t significance, and i t was necessary to show that 
there was a correlation between rej e c t i o n and the appear-
ance of cytotoxic antibody. 
Direct cytotoxicity t e s t s occasionally detected a n t i -
body by the eighth day a f t e r i n j e c t i o n and regularly by 
the ninth and tenth days (Table 2 ) . I f low t i t r e d antibody 
occurred e a r l i e r , i t could not be detected since the a n t i -
complementary action of concentrated mouse serum prohibits 
the testing of undiluted antibody. Various modifications 
of the technique were devised. 
Modification A. 
Tumour c e l l s from a compatible host were incubated 
with excess undiluted or s l i g h t l y diluted control or t e s t 
serum for twenty minutes at 37°C. The tubes were l i g h t l y 
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centrifuged and the supernatant discarded. This removed 
most of the mouse serum and the anticomplementary effect 
of the residual serum was negligible. Guinea Pig serum 
was then added as the source of complement and the tubes 
were incubated f or a further 20 minutes. 
Using t h i s modification, cytotoxic a c t i v i t y could be 
detected i n the serum of two out of three experimental 
animals on the seventh day. Serum from a stock C3H mouse 
was not cytotoxic. 
Modification B. 
Another technique modified the target c e l l s . C e l l s 
p a r t i a l l y coated with antibody were used instead of fresh 
a s c i t e s c e l l s . These c e l l s were s t i l l viable (Table 4, 
stage 1 ) . I t was thought that experimental serum with a 
r e l a t i v e l y low t i t r e d antibody might be able to complete 
the death of these c e l l s , whereas i t would be unable to 
k i l l unsensitised c e l l s . 
These pre-sensitised c e l l s were washed free of excess 
antibody and were used instead of stock c e l l s i n the cyto-
t o x i c i t y t e s t (Table 4, stage 2 ) . This t e s t showed that 
22.5$ of the s e n s i t i s e d c e l l s died i f complement was added 
on i t s own. When the experimental serum at a di l u t i o n of 
1/4 was added, G5% of the c e l l s died. There was no a c t i -
v i t y i n the a s c i t e s f l u i d . 
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This confirmed that cytotoxins could be found i n 
the serum on Day 7. 
Modification C. 
Later a more e f f i c i e n t source of complement was 
found than Guinea Pig serum. Human sera from multiple 
myeloma patients helped to detect cytotoxic a c t i v i t y as 
early as Day 5; that i s , well before there were v i s i b l e 
signs of graft r e j e c t i o n . 
Stock tumour c e l l s were pre-sensitised, e i t h e r with 
one volume of the t e s t serum from Day 5 f or with normal 
mouse serum (Table 5). The supernatant was removed and 
the pre-sensitised c e l l s tested with four different sour-
ces of complement, three multiple myeloma sera and Guinea 
Pig serum. 
The Guinea Pig serum was i n e f f e c t i v e . A l l three 
multiple myeloma sera detected the s e n s i t i s a t i o n caused 
by the t e s t serum. These sera did not a f f e c t stock 
c e l l s incubated with normal serum. 
4. The extent of the antibody pool at the time 
of graft r e j e c t i o n . 
Cytotoxic t i t r e s of 1/40 and l/SO can be found 
i n the serum on the seventh day, i f multiple myeloma 
serum i s used as complement. On day seven, the r e j e c t i o n 
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of the tumour i s . a t i t s height. Amos has shown that 
exfrace(/i>far 
the totals f l u i d volume of the mouse i s approximately 
2.0 ml. ( 9 ) , and thus the t o t a l concentration of a n t i -
body at the time of sampling can be determined. 
From the cytotoxicity t e s t s (see methods section) 
i t can be shown that where: 
0.025 ml. antibody diluted to 1/40 k i l l s 125,000 
c e l l s i n 0.025 ml. Mammalian Ringer 
then 
2,0 ml. of the same antibody undiluted would 
k i l l 400 m i l l i o n c e l l s . 
This suggests that at the time of graft r e j e c t i o n , 
providing that there was adequate complement i n the 
animal, that there was s u f f i c i e n t antibody to k i l l a l l 
the graft c e l l s present. The rate of antibody production 
was not known. 
5» The state of the tumour c e l l population during 
the r e j e c t i o n phase. 
The c e l l s i n the peritoneum represent a mixed 
population of tumour and a variety of host c e l l s and the 
proportion of these depends upon the stage of the homograft 
reaction at the time of sampling (.!£!'). At the height 
of the tumour growth, the c e l l population was predomi-
nantly neoplastic. During the early stage of r e j e c t i o n 
the proportion of tumour c e l l s was very high even though 
the t o t a l number of c e l l s was dropping rapidly. Since 
i n t h i s t h e s i s , i n t e r e s t was i n the state of the tumour 
populations, only populations which were predominantly 
tumourous were considered. The state of the t o t a l popu-
l a t i o n , therefore, was more l i k e l y to r e f l e c t the state 
of the neoplastic c e l l than the host c e l l . 
C e l l s removed from the animal on Day 5 were as sen-
s i t i v e as the stock tumour in t h e i r response to the immune 
serum being produced against them. They showed an i n t e r -
esting difference from the stock tumour i n t h e i r response 
to myeloma serum (Table 5 ) . The serum from multiple 
myelomatous patients was not cytotoxic towards stock 
tumour c e l l s , but when added to. c e l l s removed from the 
experimental animals, i t k i l l e d a proportion of these 
c e l l s . This finding suggested that a proportion of the 
c e l l s i n the peritoneum were coated with antibody on 
Day 5. I t had been shown already that cytotoxic antibody 
was detectable i n the serum by the f i f t h day a f t e r inocu-
l a t i o n . 
An indication of the extent of t h i s s e n s i t i s a t i o n 
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throughout the homograft reaction can be gained by consi-
dering the state of the individual populations, on success-
ive days, i n the nine experiments. A population was con-
sidered to show evidence of s e n s i t i s a t i o n , i f added com-
plement caused an increase of at l e a s t 10% dead i n the 
population. 
The r e s u l t s i n Table 6 indicate that many of the 
populations were s e n s i t i s e d during the c r i t i c a l period 
of graft r e j e c t i o n . A proportion of the c e l l s had s u f f i -
cient antibody to be k i l l e d i f complement was added. Other 
c e l l s might have been inadequately coated, with antibody 
but such c e l l s could not have been detected by t h i s tech-
nique. Some populations of QL;j_ had very high rates of 
s e n s i t i s a t i o n where over 50% of the c e l l s were s e n s i t i s e d . 
The tumour populations also showed signs of i r r e v e r -
s i b l e damage, for there 'was an increasing number of dead 
c e l l s i n the experimental populations, p a r t i c u l a r l y i n 
the l a t e r stages of r e j e c t i o n . Healthy tumour populations 
growing i n a susceptible s t r a i n rarely contain more than 
5% dead c e l l s . 
On Day 5> there were no populations in which more 
than 10% of the c e l l s were dead. By Day 8, 25% of the 
populations contained more than 10% dead c e l l s . This 
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percentage was never spectacular; there were rar e l y more 
than 15$ dead c e l l s i n a single population. 
SUMMARY - PART I . 
These d i r e c t observations on graft r e j e c t i o n i n the 
peritoneum show that cytotoxic antibody was produced i n 
the system, before the graft was rejected, and that suf-
f i c i e n t antibody was produced to k i l l a l l the graft c e l l s 
present i n the animal at the time of graft r e j e c t i o n . 
Antibody could not be detected i n the immediate v i c i n i t y 
of the graft; that i s , i n the a s c i t e s f l u i d u n t i l prac-
t i c a l l y a l l the tumour c e l l s had disappeared. This may 
have been due partly to the binding of antibody on to 
the surface of the tumour c e l l s . There was evidence that 
a proportion of the tumour c e l l s became f u l l y s e n s i t i s e d 
and that there was an increase i n the number of dead 
c e l l s i n the population i n the rejection phase. 
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PART I I - THE USE OF DIFFUSION CHAMBERS TO DEFINE THE 
ROLE OF ANTIBODY IN GRAFT REJECTION. 
1. The growth of tumour c e l l s i n diffusion chambers. 
A s e r i e s of tumours have been grown successfully 
i n d iffusion chambers. The tumours ofj^ten have character-
i s t i c rates of growth, but the growth curves a l l have 
e s s e n t i a l l y the same features (Graph 3 ) , ( 13 ). 
After an i n i t i a l inoculum of approximately one mi l l i o n 
c e l l s , a rapid drop i n the population always occurred. 
After twelve to twenty-four hours, the population recov-
ered and began to divide, often at a rate comparable to 
that of the a s c i t e s growing f r e e l y i n the peritoneum. 
After t h i s logarithmic phase of growth, the rate of growth 
declined, often to a mere replacement of dying c e l l s i n 
an overcrowded population* 
The growth of the tumour i n the chamber had the ad-
vantage of being independent of the genotype of the host 
mouse. A tumour grew equally well i n chambers placed i n 
the peritoneum of r e s i s t a n t and susceptible mice (Graph 4 ) . 
This suggested that the possible natural immune factors 
were of l i t t l e importance i n affecting the rate of growth 
of the tumour i n chambers. This was important f o r the 
tumour i n the experimental s e r i e s had to be grown i n r e -
s i s t a n t hosts^ hosts of the same genotype i n which the 
antibody was prepared. 
I t was important to e s t a b l i s h consistency i n the 
reproducibility of population counts i n different chambers 
i n the same experimental situ a t i o n . I t can be seen from 
the graphs plotted for seven different experiments, that 
there was reasonable agreement i n the normal growth of 
D B A 2 thymoma i n the same experimental s e r i e s and between 
s e r i e s (Graph 5 ) . 
2. The e f f e c t s of single i n j e c t i o n s of antibody. 
The D B A 2 thymoma was p a r t i c u l a r l y suitable f o r 
these experiments. I t has a rapid and continuous growth 
phase extending over a period of days and i t s c e l l s are 
known to be antibody s e n s i t i v e . From numerous experiments 
on the cytotoxic effect of antibody against t h i s tumour i n 
v i t r o , the numerical relationship between the amount of 
antibody and'cell damage was known. As l i t t l e as 0.2 ml. 
of antibody would produce permeability changes i n f i v e 
m i l l i o n lymphoma c e l l s . This was an expression of the 
a c t i v i t y of the antibody i n v i t r o , using Guinea Pig serum 
as a source of complement. These r e s u l t s were of some 
value when considering the possible doses of antibody to 
be injected f o r the i n vivo experiments (Table 9 ) . 
0.1 ml. DBA-L a n t i D B A 2 antibody was injected i n t r a -
peritoneally into animals bearing chambers containing 
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DBA2 thymoma. Other animals were injected with 0.1 ml. 
normal mouse serum. Normal mouse serum had no e f f e c t on 
the growth of the populations i n the chambers; the tumour 
c e l l s divided rapidly throughout the experimental period 
(Graph 6 ) . 
The populations receiving antibody were damaged sev-
erely. Within s i x hours of the i n j e c t i o n , the t o t a l popu-
l a t i o n had dropped from approximately 2.5 m i l l i o n to 1.2 
m i l l i o n c e l l s ; h a l f the c e l l s were lysed and 5 0 % of the 
c e l l s remaining i n the chambers were dead. Chambers sam-
pled at twenty-four hours showed that the treated popula-
tions were beginning to recover. Only 20% of the c e l l s 
were dead, and i n the l a s t eighteen hours, the s i z e of 
the population had doubled. Chambers sampled at forty-
eight and seventy-two hours showed that the rate of growth 
i n the experimental populations was equal to that i n the 
control populations. 
Antibody was injected when the tumour c e l l s were i n 
a more advanced stage of growth; a l y t i c effect was seen 
providing that s u f f i c i e n t antibody was given. This dosage 
e f f e c t was more apparent when different volumes of the 
antibody were given at the same point on the growth curve 
(Graph 7 ) . Here, the l y t i c e f f e c t was d i r e c t l y related to 
the volume of antibody given, but i n no instance did the 
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antibody completely l y s e the population. The damage caused 
by antibody was always maximal within 24 hours. Recovery 
and continued growth of the population took place to restore 
the rate of growth to that of the control population. 
3. The e f f e c t s of multiple i n j e c t i o n s of antibody. 
I f a r e l a t i v e l y large volume of antibody (0.3 ml.) 
was given to 1,000,000 D B A 2 c e l l s at the beginning of t h e i r 
active growth phase, great destruction took place i n i t i a l l y , 
and even at 24 hours there was l i t t l e sign of the residual 
population recovering. A further i n j e c t i o n of 0.3 ml. of 
antibody was given to two chambers i n the hope that com-
plete destruction of the population might occur. Recovery 
and growth of these tumours populations was delayed but 
took place 1-2 days a f t e r the l a s t i n j e c t i o n of the a n t i -
body (Graph g). 
In the next experiment (Graph 9) the antibody i n j e c -
tions were given daily for four days beginning on the 
second day of the growth phase. Twenty four hours a f t e r 
the f i r s t dose of antibody, the treated population t o t a l l e d 
one m i l l i o n . The number of tumour c e l l s remained constant 
during the course of the antibody i n j e c t i o n s . No further 
l y s i s of the population was caused by i n j e c t i n g additional 
antibody. Indeed, three days a f t e r the antibody i n j e c t i o n s 
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stopped, the recovery of the tumour became apparent and 
the following day the rate of growth was comparable to 
that i n the control populations. Only a proportion of 
the tumour population was therefore susceptible to the 
action of antibody. The apparent resistance to the e f f e c t s 
of antibody by the residual c e l l s and t h e i r subsequent 
growth, might have been due to two fa c t o r s : 
1. I n s u f f i c i e n t antibody in the chambers. 
2. Selection of an antibody r e s i s t a n t population. 
Experiments were devised to study these possible f a c t o r s . 
k. The detection of antibody i n the chamber, 
a. Haemagglut i n i n s . 
Haemagglutinating antibody could be detected 
e a s i l y i n the chamber two to four hours a f t e r i t s i n j e c -
t ion into the peritoneum ( 13 ). During the course of 
successive antibody i n j e c t i o n s , the t i t r e i n the chambers 
rose steadily and antibody was present, even four days 
a f t e r the l a s t i n j e c t i o n of antibody (Graph 9 ) . At t h i s 
time, the antibody l e v e l i n the chamber was almost as 
high as i n the serum, suggesting that r e l a t i v e l y l i t t l e 
antibody was needed to s e n s i t i s e the tumour c e l l s i n the 
chamber. The s e n s i t i s a t i o n does not affect the rate of 
growth. Many se n s i t i s e d populations, i n spite of being 
bathed i n antibody, were dividing at as rapid a rate as 
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control untreated populations. 
b. The presence of cytotoxic antibody i n the 
chamber. 
I t was known that immune serum has both 
haemagglutinating and cytotoxic properties. I t was possi-
ble that these were properties of two d i s t i n c t antibodies 
with the same genetic s p e c i f i c i t y and although there was 
excess haemagglutinin i n the chamber f l u i d , cytotoxic a n t i -
bodies might have been lacking. Chamber f l u i d s from cer-
t a i n stages i n the multiple i n j e c t i o n s e r i e s were studied 
f o r cytotoxic a c t i v i t y . 
The chamber f l u i d s were tested, i n v i t r o , against 
fresh D B A 2 thymoma c e l l s , using Guinea Pig serum as a 
source of complement (Table Cytotoxic antibody was 
detectable i n the chamber f l u i d s , 24 hours a f t e r the f i r s t 
i n j e c t i o n of antibody, u n t i l at l e a s t three days a f t e r the 
l a s t i n j e c t i o n of antibody. At no time during t h i s period 
was cytotoxic antibody lacking from the chambers. The 
a c t i v i t y present i n each individual chamber was according 
to i n v i t r o studies, more than s u f f i c i e n t to k i l l the 
tumour c e l l s growing in the chamber (Table 9 h There was 
considerable cytotoxic a c t i v i t y i n the serum. 
5. Studies to determine whether c e l l s r e s i s t e n t to 
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antibody have been selected from the population. 
a. The s e n s i t i v i t y of the residual c e l l s re-
maining i n the population to antibody i n v i t r o i 
The residual c e l l s were taken from the 
chamber that had received four in j e c t i o n s of antibody and 
was sampled three days a f t e r the l a s t injection.; The 
a c t i v i t y of these c e l l s was compared to that of two con-
t r o l populations that had had no previous contact with 
antibodyi Antibody and complement were added i n v i t r o 
(Table 10). 
The c e l l s from the chamber i n the antibody treated 
host were badly damaged already for they showed a high 
degree of staining without further treatment. I f com-
plement was added to t h i s population, the great majority 
of the rest of the population died. This suggested that 
antibody was bound to these c e l l s i n vivo for the comple-
ment alone was not cytotoxic. The addition of fresh anti' 
body to the system did not increase the number of damaged 
c e l l s i n the population even though t h i s antibody, i n the 
presence of complement, was highly active against the 
control c e l l s . There appeared to be a few refractory 
c e l l s i n a l l tumour populations. 
b. The growth of previously s e n s i t i s e d c e l l s i n 
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l i g h t l y immunised animals. 
Several s e n s i t i s e d populations were subjected to 
a further selection pressure provided by growing the c e l l s 
i n DBA-L animals l i g h t l y immunised against the DBA 2 thymoma. 
This might have indicated whether the f a i l u r e of the 
antibody to k i l l a l l of the c e l l s i n the chamber was due 
to the emergence of an antibody r e s i s t e n t population. 
Such a r e s i s t e n t c e l l type would be favoured when trans-
planted into l i g h t l y immunised hosts. 
c. A comparison of the s u s c e p t i b i l i t y of the 
"passaged"DBA,., thymoma with the stock tumour 
to cytotoxic antibody. 
The r e s u l t s of the in v i t r o cytotoxicity 
t e s t (Table 11) suggested that the"passaged" l i n e might 
be more antibody r e s i s t e n t than the stock DBA2 thymoma^ 
The experimental tumour, at t h i s time, had been passaged 
through f i v e generations of immunised animals. 
Both tumours were grown i n chambers. Both grew at 
approximately the same rate, and when the populations 
reached one million, 0.3 ml. antibody was injected into 
animals from each group. The chambers were sampled 
twenty four hours l a t e r . The populations i n each group 
were markedly susceptible to the antibody. The next gen-
eration of"passaged" c e l l s were tested again, i n vivo, and 
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showed a s i m i l a r degree of s u s c e p t i b i l i t y ^ r - a p n . 10). 
SUMMARY - PART I I 
Antibody has considerable immediate l y t i c and damag-
i n g e f f e c t s on a tumour p o p u l a t i o n , growing i n a d i f f u s i o n 
chamber. Some of the c e l l s d i d not l y s e and i n f a c t grew 
i n the presence of antibody. These c e l l s were s e n s i t i s e d 
w i t h antibody and became i r r e v e r s i b l y damaged i f complement 
was added i n v i t r o . 
I t d i d not appear t h a t the p o p u l a t i o n of c e l l s remain-
i n g the chamber was i n h e r e n t l y r e s i s t e n t t o the a c t i o n of 
antibody. 
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PART I I I - THE ROLE OF COMPLEMENT IN AUGMENTING THE 
EFFECTS OF ANTIBODY IN VIVO. 
Lysis i s known t o be a two stage process needing 
s p e c i f i c antibody b i n d i n g a t the a n t i g e n i c s i t e s , f o l l o w e d 
by the f i x a t i o n of complement ( #4 ). I t may be t h a t t h e r e 
was i n s u f f i c i e n t complement i n the chambers t o achieve the 
f u l l c y t o t o x i c e f f e c t s of the antibody. 
A p o p u l a t i o n of c e l l s t h a t had been subjected t o a 
ser i e s of d a i l y i n j e c t i o n s of antibody was st u d i e d . Here 
the maximum l y t i c e f f e c t s of the antibody would have been 
reached; the c e l l s would be f u l l y s e n s i t i s e d w i t h antibody 
and there would be f r e e antibody i n the chamber. Comple-
ment would be added a t t h i s stage. Guinea Pig serum was 
used f o r i t was known t o be a r e l i a b l e source o f complement. 
1. The e f f e c t s o f a s i n g l e i n j e c t i o n of complement. 
Animals received t h r e e d a i l y i n j e c t i o n s t o r e -
ceive a t o t a l of 0.9 ml. antibody. Varying doses of 
Guinea Pig serum were given a t the same time as the l a s t 
i n j e c t i o n of antibody (Graph 11). 
Guinea Pig serum alone had l i t t l e e f f e c t on an un-
t r e a t e d p o p u l a t i o n . There was also very l i t t l e d i f f e r e n c e 
between populations t r e a t e d w i t h antibody alone and those 
which had received a d d i t i o n a l small volumes of Guinea Pig 
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serum - 0.2 ml. When l a r g e r volumes of Guinea Pig serum 
were i n j e c t e d there was a considerable increase i n l y s i s 
compared w i t h the c o n t r o l s , the i n t e n s i t y of e f f e c t appear-
i n g t o be d i r e c t l y r e l a t e d t o the volume of Guinea Pig 
serum given. P r a c t i c a l d i f f i c u l t i e s were encountered when 
l a r g e r volumes of serum were given. Attempts were made 
t o i n j e c t 2.0 ml. but the serum leaked through the suture 
wound making i t impossible t o know the volume of Guinea 
Pig serum remaining i n the peritoneum. 
The r e s i d u a l c e l l s i n these experimental chambers 
were f u l l y s e n s i t i s e d w i t h antibody, f o r they became i r r e -
v e r s i b l y damaged when a d d i t i o n a l Guinea Pig serum was 
added i n v i t r o . 
Mouse serum though i n e f f e c t i v e as a source of com-
plement, i n v i t r o , probably has some a c t i v i t y i n v i v o , 
since i n the e a r l y stages o f antibody i n j e c t i o n , l y s i s 
does take place i n the chambers. A d d i t i o n a l i n j e c t e d 
mouse serum may, t h e r e f o r e , be able t o enhance the l y t i c 
system i n v i v o . 
Freshly drawn mouse serum from DBA2 mice was i n j e c t e d 
i n t o antibody t r e a t e d animals bearing chambers. The r e -
s u l t was i n t e r e s t i n g ; not only d i d the mouse serum cause 
pronounced l y s i s , but the degree of l y s i s was comparable 
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t o t h a t produced by the same volume o f Guinea Pig serum 
(Graph 12). I t was known t h a t i n v i t r o , mouse serum par-
t i a l l y i n a c t i v a t e d Guinea Pig eomplement and t h a t much of 
the a c t i v i t y of the Guinea Pig serum may be l o s t i n v i v o . 
These r e s u l t s suggested t h a t small amounts of complement 
augmented the e f f e c t o f antibody and t h a t mouse serum 
supplied t h i s complement as e f f i c i e n t l y as d i d the Guinea 
Pig serum (Graph 13). Normal mouse serum added t o the 
u n s e n s i t i s e d c e l l c o n t r o l p o p u l a t i o n had no detectable 
e f f e c t . 
2. A d e t a i l e d study o f the e f f e c t s of antibody and 
Complement. 
The e a r l i e r experiments have e s t a b l i s h e d t h a t 
antibody could cause l y s i s of the tumour p o p u l a t i o n , and 
t h a t complement could augment t h i s e f f e c t . I n a l l these 
experiments, the chambers were sampled at twenty f o u r hour 
i n t e r v a l s , so t h a t the general f e a t u r e s o f the r e a c t i o n 
were apparent. I n the f o l l o w i n g experiment the e f f e c t s 
of antibody and complement were watched i n d e t a i l . 
The lymphoma ji#2 was used. The antibody was heated 
a t 56°C. f o r twenty minutes t o remove the heat l a b i l e 
components of complement present i n the immune serum. Pre-
l i m i n a r y t e s t i n g i n v i t r o showed t h a t the heated antibody 
- 65 -
was moderately c y t o t o x i c , i n the presence of f r e s h com-
plement. 0.4 ml. antibody was t h e r e f o r e i n j e c t e d (Graph 14). 
I t could be shown t h a t n e a r l y 50% of the p o p u l a t i o n 
had l y s e d w i t h i n two t o f o u r hours of the i n j e c t i o n of the 
antibody. The remaining c e l l s i n each p o p u l a t i o n were 
f u l l y s e n s i t i s e d w i t h antibody. Antibody alone appeared 
t o have no f u r t h e r e f f e c t and the po p u l a t i o n remained 
s t a b l e f o r the next f o u r hours. Eight hours a f t e r the 
i n j e c t i o n o f the antibody, 1 ml. of f r e s h mouse serum was 
i n j e c t e d i n t o each of these animals. A chamber taken one 
hour l a t e r showed t h a t h a l f the remaining p o p u l a t i o n had 
l y s e d and by two hours p r a c t i c a l l y the whole p o p u l a t i o n 
was l y s e d . Meanwhile, i n the c o n t r o l i n j e c t e d w i t h a n t i -
body alone, the p o p u l a t i o n showed m i t o t i c a c t i v i t y , and 
the c e l l s began t o increase i n number. 
3. The e f f e c t s of multiple, i n j e c t i o n s of complement. 
The previous experiment suggested t h a t p r a c t i c a l l y 
the whole tumour p o p u l a t i o n could be destroyed i f the com-
plement l e v e l i n the system was r a i s e d . M u l t i p l e i n j e c -
t i o n s of complement were given t o s e n s i t i s e d populations, 
where t h e r e was known t o be excess antibody i n the chambers. 
0.2 ml. o f antibody was given t o a p o p u l a t i o n of L#2 
on Day 3 and Day 4 (Graph 15). Twenty-four hours a f t e r t he 
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l a s t I n j e c t i o n the antibody group remained a t a t o t a l o f 
two m i l l i o n c e l l s , whereas the c e l l c o n t r o l p o p u l a t i o n had 
reached a t o t a l of e i g h t m i l l i o n c e l l s . By the f o l l o w i n g 
day the experimental p o p u l a t i o n had broken f r e e from the 
r e s t r a i n t of the antibody, i n s p i t e of th e r e being a n t i -
body w i t h a t i t r e of 256 i n the chambers. This confirmed 
e a r l i e r experiments i n which a f t e r i n i t i a l l y t i c e f f e c t s , 
a p o p u l a t i o n would grow i n the presence of antibody. 
Some animals were given a s e r i e s of d a i l y i n j e c t i o n s 
of complement, i n a d d i t i o n t o the antibody (see i n j e c t i o n 
schedule, Graph 15); the tumour c e l l s d i d not recover. 
Four days a f t e r the l a s t i n j e c t i o n o f antibody, these 
populations remained at 2 m i l l i o n , whereas the populations 
t r e a t e d w i t h antibody alone or w i t h mouse serum alone had 
the same high c e l l number as t h e untreated populations. 
Even under these experimental c o n d i t i o n s , i t had not 
been possible t o destroy the tumour p o p u l a t i o n . I t was 
known t h a t excess antibody had been i n j e c t e d , f o r i t could 
be detected i n the chambers. A t o t a l of 4 ml. normal 
mouse serum had been i n j e c t e d i n t o each mouse; i t was 
assumed t h a t t h i s would boost the l e v e l of a v a i l a b l e com-
plement i n the peritoneum, but u n f o r t u n a t e l y a t t h i s 
p o i n t , t h e r e was no s a t i s f a c t o r y method of assaying mouse 
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complement i n v i t r o . There was no means o f knowing how 
much complement remained a c t i v e and had a c t u a l l y entered 
the chamber. 
4. The i n v i t r o assay of mouse complement. 
The.level of complement i n mouse serum cannot be 
determined by the c l a s s i c a l r a b b i t a n t i sheep haemolysin 
system. Even d i l u t e d mouse serum w i l l not haemolyse sheep 
c e l l s p r e v i o u s l y s e n s i t i s e d w i t h r a b b i t a n t i sheep haemo-
l y s i n . This i s i n co n t r a s t w i t h the serum o f many other 
species where the complement l e v e l s are so high , t h a t the 
serum has t o be d i l u t e d several hundred f o l d , i n order t o 
determine the d i l u t i o n a t which the serum no longer com-
plements the r e a c t i o n ( 22 ). 
Eve n t u a l l y , i t was found t h a t mouse serum would com-
plement a mouse antihuman red c e l l l y t i c system. Even 
when the mouse serum was t e s t e d at one p a r t i n two o f t e n 
the red c e l l s were not completely haemolysed. The com-
plement l e v e l s i n the p e r i t o n e a l f l u i d were considerably 
lower and the r e was p r a c t i c a l l y no a c t i v i t y at a l l i n the 
chamber f l u i d (Graph 16). 
This was the most p h y s i o l o g i c a l system t h a t could be 
devised t o t e s t mouse complement. I t could not detect 
complement i n the chamber though undoubtedly some comple-
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m e n t i s present. 
The complement l e v e l s were determined a f t e r the a n i -
mals had received 1 ml. volumes o f f r e s h l y c o l l e c t e d mouse 
serum. I t was hoped t h a t these i n j e c t i o n s would boost the 
complement i n the peritoneum and t h e r e f o r e t he complement 
i n the chambers t o l e v e l s measurable by t h i s technique. 
Graph 16 shows t h a t there was no detectable increase i n 
the l e v e l s of complement i n the peritoneum o r the chamber 
f l u i d . 
I t i s known t h a t t h i s t e s t w i l l d etect only complete 
complement. There are f o u r components of complement, and 
l a c k of any one component prevents l y s i s . Mouse serum 
may, t h e r e f o r e , only be l a c k i n g i n c e r t a i n complement com-
ponents (31) or i t may be t h a t c e r t a i n i n h i b i t o r s are ac-
t i v a t e d i n v i t r o (#5). 
Attempts t o concentrate mouse complement by s a l t pre-
c i p i t a t i o n or by ethanol f r a c t i o n a t i o n were unsuccessful. 
This was probably due t o the extreme l a b i l i t y of complement 
and the i n i t i a l l y low l e v e l of complement (or c e r t a i n com-
ponents) i n the mouse, r e l a t i v e t o other species (77). 
SUMMARY - PART I I I 
Passively t r a n s f e r r e d complement can increase the 
damaging e f f e c t s of antibody on a tumour p o p u l a t i o n i n a 
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chamber. Neither antibody alone, nor antibody w i t h a d d i -
t i o n a l complement can destroy the whole p o p u l a t i o n . The 
i n i t i a l l e v e l o f complement i n the chamber appears t o be 
very low, and even the a d d i t i o n o f complement t o the system 
does not r e s u l t i n a detectable increase i n the l e v e l of 
complement i n the chamber. Some complement obviously d i d 
ente r the chamber, f o r th e r e i s i n i t i a l l y s i s of the popu-
l a t i o n when antibody alone i s added. The a d d i t i o n of 
guinea p i g serum and normal mouse serum produced an i n -
creased e f f e c t . 
Lack of complement appears t o l i m i t the f u l l poten-
t i a l e f f e c t of antibody. 
- 70 -
DISCUSSION 
There i s no doubt that the isoantibody c i r c u l a t i n g 
i n the immune host has a c t i v i t y against the tumour. 
Gorer and 0'Gorman have shown cytotoxic properties i n 
v i t r o (59), and t h i s has been confirmed by Amos.and 
Wakefield (15), Winn (123) and others. Gorer and Amos 
had previously shown that such antibody would suppress 
the growth of tumour c e l l s i n vivo (56). From neither 
set of experiments was i t possible to say that antibody 
did i n fact k i l l tumour c e l l s i n vivo. I n one case, 
heterologous complement was added to the system i n v i t r o ; 
the other, although i n vivo, did not preclude any a c t i v -
i t y by the host c e l l s . 
The evidence presented here shows that antibody i s 
able to damage tumour c e l l s d i r e c t l y within the animal 
and that t h i s damage can take place i n the absence of 
host c e l l s . A large proportion of the c e l l s are completely 
lysed; other c e l l s die, but e i t h e r do not l y s e or have not 
reached that stage at the time of sampling. 
The f a c t that antibody i s active but quite dependent 
upon an ef f e c t i v e source of complement has been empha-
sised by the techniques used (see 60). Antibody k i l l s a 
large number of c e l l s i n the chamber, but a residual 
- 71 -
population remains that w i l l grow rapidly even i n the 
presence of antibody and i n spite of the c e l l s having 
antibody bound to t h e i r surfaces. Direct measurements 
showed that there was i n s u f f i c i e n t complement i n the 
system. 
The chamber i t s e l f was not anticomplementary. The 
membranes are to some extent a b a r r i e r to the diffusion 
of complement, but the f a i l u r e to demonstrate complement 
e i t h e r i n the peritoneal f l u i d , or i n the chamber, a f t e r 
the i n j e c t i o n of large amounts of normal serum into the 
peritoneal cavity, suggests that e i t h e r the complement 
i s -leaving the peritoneum very rapidly or else i t i s 
being inactivated. An i n h i b i t o r of mouse complement has 
recently been described by Mayer and h i s colleagues (35). 
Attempts to boost complement were successful i n that the 
potential of the antibody was raised by the addition of 
normal serum, but i t cannot be said that the maximal 
ef f e c t of antibody has been demonstrated u n t i l i t can be 
shown that complete complement i s present i n excess. 
The l y t i c action of antibody was very marked i n 
most experiments, but i t proved impossible to destroy 
the whole population. Although t h i s was partly due to 
the lack of complement i t may also have been due to the 
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refractory state of some of the c e l l s . I t i s known 
from cytotoxicity t e s t s i n v i t r o that the c e l l s i n any 
a s c i t e s population vary in t h e i r s u s c e p t i b i l i t y to a n t i 
body and complement. Often from 2-6% of the a s c i t e s 
c e l l s seem quite i n s e n s i t i v e and Waksman has suggested 
a s i m i l a r range of s u s c e p t i b i l i t y i n a red c e l l popula-
tion (119). I t i s l i k e l y that these are the immature 
c e l l s of the population, for i t i s known that the c e l l u 
l a r antigens take time to f u l l y develop (119). 
E a r l i e r , Hauschka has shown that immunologically 
r e s i s t e n t variants can be selected from a tumour (64). 
Hauschka and Amos showed that long transplanted tumours 
frequently s h i f t from a predominantly diploid to a poly-
ploid population and that often these populations are 
progressively l e s s vulnerable to immunological attack 
( 6 ) , (65). Perhaps i t i s t h i s nucleus of r e l a t i v e l y 
i n e r t c e l l s i n each population that can survive multiple 
i n j e c t i o n s of antibody. 
I t i s known that these c e l l s w i l l continue to grow 
when transplanted to the peritoneal cavity of incompat-
i b l e mice even i f the new host i s immunised mildly. 
Since these c e l l s have antibody bound to t h e i r surfaces, 
t h i s refractory state may be due to the c e l l s having 
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l o s t t he a b i l i t y t o bind mouse complement. On t h e other 
hand, t h i s e f f e c t may be due merely t o the low l e v e l of 
complement i n the abdominal c a v i t y of the new host. 
This would prevent a s i g n i f i c a n t degree of l y s i s . 
To t e s t the hypothesis t h a t these c e l l s were r e f r a c -
t o r y , f i v e s e r i a l t r a n s f e r s of the p o p u l a t i o n were made 
through weakly immunised hosts. I n v i t r o , there was no 
detectable s h i f t i n the s e n s i t i v i t y t o antibody; the 
tumours grown i n chambers showed the same r e l a t i v e sus-
c e p t i b i l i t y t o l y s i s as d i d the stock tumour. This 
suggests n e i t h e r the a b i l i t y of the c e l l s t o bi n d a n t i -
body nor the a b i l i t y t o f i x mouse complement was perma-
n e n t l y impaired. 
These experiments show t h a t even w i t h lymphoma 
c e l l s known t o be antibody s e n s i t i v e , there are v a r i a -
t i o n s i n the response of the i n d i v i d u a l c e l l s t o the 
antibody. I t cannot be said t h a t t h i s i s due t o the 
inhe r e n t mosaic character of the p o p u l a t i o n , f o r i t i s 
c e r t a i n l y due i n p a r t t o t h e t e c h n i c a l d i f f i c u l t i e s i n 
producing adequate complement l e v e l s a t the r e a c t i o n 
s i t e . 
There i s marked v a r i a t i o n between t i s s u e s i n t h e i r 
s u s c e p t i b i l i t y t o antibody; lymphomas are vul n e r a b l e (112) 
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carcinomas, sarcomas and skin show l e s s s e n s i t i v i t y (21+), 
(123). These t i s s u e s are very l i k e l y to vary i n t h e i r 
capacity to bind antibody and complement. 
Hauschka and Amos have shown that within a mixed 
population of diploid and polyploid c e l l s , that the 
polyploid c e l l s often have r e l a t i v e l y fewer antigenic 
s i t e s than t h e i r diploid counterparts (65). Winn has 
shown that s i m i l a r differences occur between t i s s u e s . 
He believes that Sarcoma I has only k% of the antigenic 
s i t e s of 6C3HED (123), and t h i s would l i m i t severely the 
amount of antibody that could be bound by Sarcoma I . 
On the other hand, some tumours can absorb antibody, so 
that c l e a r l y antigenic s i t e s are present and accessible, 
and yet the c e l l s are refractory (123). This may be due 
to variations i n the a b i l i t y of antibodies to bind com-
plement, f o r Goodman has shown that differences do e x i s t 
(49). Complement f i x a t i o n involves the sequential bind-
ing of a l l the four components of complement, and damage 
does not occur u n t i l t h i s sequence of f i x a t i o n i s com-
plete. The components are often unstable and i f the 
reaction does not proceed to completion within a few 
minutes, individual factors may decay or dissociate from 
the complex. The f i x a t i o n of C"^  i n adequate amounts and 
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the a v a i l a b i l i t y of a l l the other components i s e s s e n t i a l 
for l y s i s (#4). Mayer has stressed that providing•the 
whole sequence of binding i s completed, a c e l l might 
ly s e even i f only one s i t e i s affected ( 8 4 ) . The c e l l 
i s more vulnerable i f i t has a greater number of s i t e s , 
and l y s i s w i l l be more rapid i f more s i t e s are affected. 
Variations i n the response of different types of 
tumour to the cytotoxic a c t i v i t y of antibody have been 
shown by the i n v i t r o t e s t , but these variations may 
be of significance only i n so f a r as they r e f l e c t the 
actual behaviour of the c e l l s i n vivo. I t i s believed 
that cytotoxic a c t i v i t y i s more of a functional measure-
ment of antibody than other i n v i t r o t e s t s , such as those 
involving agglutination, but i t i s recognized that cyto-
toxic a c t i v i t y i s only one rather r e s t r i c t e d measure of 
humoral immunity. Other humoral factors present i n the 
animal may not be e f f e c t i v e i n the i n v i t r o t e s t . The 
i n v i t r o effect i s c e r t a i n l y l e s s e f f e c t i v e than that 
i n vivo, f o r whereas complete l y s i s of many of the c e l l s 
occurred i n the chamber experiments, most of the c e l l s 
i n the i n v i t r o t e s t s had increased permeability and 
were presumably dead, but did not l y s e . As a c o r r o l l a r y 
to t h i s , Kidd showed that heteroantibody and complement 
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did not a f f e c t Brown Pearce carcinoma c e l l s even a f t e r 
eighteen hours i n v i t r o ( 7 0 ) . Yet the same antibody-
transferred i n vivo completely inhibited the growth of 
such c e l l s . 
Because of these drawbacks, many workers have pre-
ferred to study transferred immunity i n , i n vivo s i t u a -
tions, not only to get a more accurate idea of the sus-
c e p t i b i l i t y of the individual c e l l s to antibody, but 
also to mimic the conditions during the active r e j e c t i o n 
of a whole ti s s u e graft. These are two quite different 
goals and sometimes, i n the interpretation of r e s u l t s , 
t h i s has led to a misunderstanding of the action of 
antibody. 
The physiological conditions in vivo are an obvious 
improvement over the t e s t tube, but the animals are not 
ac t i v e l y immune; they merely supply the environment i n 
which the antibody and c e l l s meet. 
One of the major differences between the a c t i v e l y 
and the passively immunised animal i s that i n the former, 
there are acute vascular changes res u l t i n g i n increased 
permeability. These might allow antibody to flow more 
fre e l y into the graft area. In the passively immunised 
animal, t h i s reaction does not occur and the concentration 
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of antibody i n the graft s i t e or the degree of penetra-
tion into the graft i s not known. Gorer and Amos have 
shown that, although passively transferred antibody 
prevented the growth of leukotic c e l l s , the growth of 
r e l a t i v e l y few leukotic c e l l s was inhibited (56). There 
was great excess of antibody c i r c u l a t i n g i n tumour bear-
ing animals, but r e l a t i v e l y l i t t l e antibody was absorbed 
by the tumour (5)- I t was Amos' opinion that much of 
the antibody did not reach the graft. 
Another possible difference i s that the complement 
may not be produced at the same rate as in the a c t i v e l y 
immune animal. Indeed, Winn has shown recently that 
the e f f e c t of antibody i n the neut r a l i s a t i o n t e s t i s 
greatly improved i f complement i s injected into the 
experimental animals (123). I f neither antibody nor 
complement reach the individual graft c e l l s i n adequate 
concentrations, i t i s l i t t l e wonder that antibody i s 
not thought to a f f e c t the growth of cer t a i n g r a f t s . 
Technical d i f f i c u l t i e s such as these have plagued 
investigations into the relationship between graft and 
host. The f a i l u r e of passively transferred antibody 
to cause the regression of a skin graft (23) has been 
extrapolated to the conclusion that humoral antibody 
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plays no part i n skin graft r e j e c t i o n (#6), This.,' con-
clusion i s unwarranted because the conditions in the 
passively transferred animal do not approach those i n 
the a c t i v e l y immunised host. 
Dissociated epidermal c e l l s show some s e n s i t i v i t y 
to antibody i n v i t r o (24) and now that Stetson has used 
t o p i c a l applications of vasodilator substances, i t i s 
possible to provoke an accelerated r e j e c t i o n of skin 
grafts i n passively immunised but not i n normal mice (110). 
Thus one of the possible technical objections have been 
overcome. I t i s not known what effect a r t i f i c i a l l y 
r a i s i n g the l e v e l of complement i n the graft area would 
have on the apparent a c t i v i t y of antibody. 
I t would seem that most c e l l s appear to be suscept-
i b l e to antibody, but t h i s conclusion has been reached 
by a s e r i e s of techniques designed to define the potential 
a c t i v i t y of antibody rather than to define the i n vivo 
situa t i o n i n the course of graft r e j e c t i o n . I t i s , 
therefore, by no means proved that antibody e l i c i t s 
graft r e j e c t i o n . 
The present studies do show, however, that cyto-
toxic antibody was produced by the a c t i v e l y immune animal. 
I t was present i n the animal before there were v i s i b l e 
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signs of graft r e j e c t i o n and at t h i s time, there was 
s u f f i c i e n t t o t a l antibody i n the serum to k i l l the 
graft. 
The graft appeared to absorb the antibody a c t i v e l y , 
for while there were tumour c e l l s i n the peritoneum, 
there was no antibody detectable in the v i c i n i t y of the 
graft, even though the l e v e l of antibody i n the serum 
was quite high. Immediately a f t e r the tumour disappeared 
from the peritoneum, antibody was detected l o c a l l y , and 
i t increased rapidly in concentration. The sudden appear-
ance of antibody i n the peritoneum could be due e i t h e r to 
a transient increase i n permeability of the peritoneal 
wall or to the f a c t that antibody was being formed i n 
the peritoneum throughout the re j e c t i o n phase. 
Gorer noticed a sudden drop in the serum t i t r e on 
Day 6, during the r e j e c t i o n of E.L. 4 i n the subcutaneous 
si t e , such as would be associated with a sudden change i n 
permeability i n the area of the graft (5#). I t i s i n t e r -
esting that i n these current experiments with L1210 i n 
the peritoneal s i t e that a s i m i l a r drop was noticed on 
Day 7 at the height of the re j e c t i o n phase. 
These r e s u l t s contrast markedly with the r e s u l t s of 
Amos i n the passively immune state. Here, i f the tumour 
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was placed subcutaneously, l i t t l e antibody was absorbed 
on to the tumour c e l l s ( 5 ) . 
There was some in d i r e c t evidence that antibody be-
comes bound to the tumour c e l l s during t h e i r r e j e c t i o n . 
An increasing number of the c e l l s become se n s i t i s e d and 
i n c e r t a i n instances, e.g. QLj_ i n C3H animals p r a c t i c a l l y 
the whole tumour population was affected, at the height 
of r e j e c t i o n . The fate of these affected c e l l s was not 
known. I t was d i f f i c u l t to guage whether any direct 
l y s i s occurred as i n the diffusion chamber, but many of 
the tumour c e l l s were found toobe dead at the time of 
sampling. Some of these c e l l s were morphologically nor-
mal, but a few showed gross degenerative changes. 
I t i s not known what part immune host c e l l s play i n 
these reactions. I t i s known that many h i s t i o c y t e s 
invaded the graft area during r e j e c t i o n . These c e l l s 
may be c y t o l y t i c ; they were cer t a i n l y phagocytic. Where 
the h i s t i o c y t e response was sluggish and the c e l l s were 
rather inactive, there was often an accumulation of 
pycnotic c e l l s (131). This underlines the f a c t that the 
hi s t i o c y t e acts as a scavenger, but there may be l e s s 
obvious methods of host c e l l p a r t icipation. I t i s by 
no means ce r t a i n that h i s t i o c y t e s ingest only dead c e l l s , 
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s e n s i t i s e d c e l l s or quite healthy tumour c e l l s may be 
vulnerable to attack. 
The evidence f o r antibodies as a factor i n graft 
r e j e c t i o n may be restated: cytotoxic antibodies are 
formed before the v i s i b l e onset of graft r e j e c t i o n ; the 
antibody t i t r e rapidly increases as the tumour mass de-
creases; the tumour c e l l s are found to be s e n s i t i s e d 
before they are destroyed. By suitable methods, many 
types of c e l l s and not j u s t lymphomas (71), can be shown 
to be se n s i t i v e to antibody. 
Graft r e j e c t i o n i s a complex procedure and since 
there i s no evidence to show how closely the si t u a t i o n 
at the graft s i t e resembles any experimental in vivo 
system, i t i s j u s t i f i a b l e to-consider the animal's re-
sponse against different types of antigen. Much of the 
evidence f o r the a c t i v i t y of the host c e l l s comes from 
investigations into the response against tuberculin or 
other simpler antigens. There are two sharply defined 
reactions. Some antigens such as p i c r y l chloride e l i c i t 
an immediate inflammatory response when injected into 
an immune host (73); others do not provoke a response 
for 24 to 4# hours (see 27). This difference i n timing 
i s quite c h a r a c t e r i s t i c and seems to r e f l e c t fundamental 
- 32 -
differences i n the nature of the two immune responses. 
Since the immediate response i s mediated by serum and 
the delayed type only by c e l l s there i s some s i m i l a r i t y 
between an animal response to graft t i s s u e and to simpler 
antigens (74). 
I t i s widely held that tissue grafts, notably those 
refractory to antibody, e l i c i t a delayed hypersensitivity 
reaction, and that antibody plays no role i n graft r e j e c -
tion (&&). Hildemann and Medawar have c i t e d the points 
in favour of t h i s idea (66). The most cogent evidence 
stems from the f a c t that the rejection of many t i s s u e s 
i s mediated only by immune c e l l s and t h i s was supported 
by tne early work i n diffusion chambers (121). This 
claim must be softened. 
A l g i r e T s early work i n diffusion chambers now should 
be considered evidence that the immune c e l l ' i s r e l a -
t i v e l y superior to antibody i n mediating graft r e j e c t i o n 
( 1 ) . His work on a heteroiramune system (2) and t h i s 
present work i n an isoimmune situation show that when 
antibody i s passively transferred, a diffusion chamber 
does not prevent damage occurring to the graft. 
I t i s not even c e r t a i n whether delayed type hyper-
s e n s i t i v i t y i s a unique immune state. There i s some 
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recent evidence to suggest that the delayed response 
i s only a r e f l e c t i o n of incomplete immunity; that i s , 
a stage i n the development of complete immunity (104). 
Leskovitz and Waksman have shown that often, i n j e c t i o n 
of the antigen by the intradermal route produces both 
an immediate and a delayed response, whereas the same 
antigen w i l l e l i c i t only an immediate response involving 
complete antibody when injected intravenously (76). 
Grafts p a r t i c u l a r l y of skin are placed most f r e -
quently in the intradermal s i t e . There i s evidence that 
these skin grafts produce delayed type response (30) 
although Milgrom has shown that skin grafts also e l i c i t 
c e r t a i n immediate type responses (91). Further evidence 
from patients lacking gamma globulin and therefore hav-
ing negligible or no antibody producing capacity, show 
that they can tolerate skin homografts i n d e f i n i t e l y . 
Yet these patients are able to acquire delayed hypersen-
s i t i v i t y against simpler antigens (48). 
I t i s premature to consider the skin homograft 
reaction purely as a delayed type of response, and the 
evidence from leukotic grafts suggests quite the reverse. 
I t would seem more l i k e l y that in the re j e c t i o n of t i s s u e 
grafts both immune c e l l s and humoral antibody play a 
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role, and that the r e l a t i v e importance of each response 
depends on the nature of the grafted t i s s u e . This would 
give the animal the most e f f i c i e n t and v e r s a t i l e defence 
system. 
Studies on the c e l l u l a r mechanism of graft r e j e c -
tion are, however, usually carried out with complex mix-
tures of c e l l s . The lymph node c e l l s used i n the adop-
t i v e t r a n s f e r studies of Mitchison and by others are a 
mixture of c e l l types ranging from multipotential r e t i -
culum c e l l s to mature lymphocytes. The apparent super-
i o r i t y of t h i s lymphoid tissue over humoral antibody may 
be due to the concentrated l e v e l s of humoral antibody 
known to be produced by lymphoid c e l l s . A seldom consi-
dered p o s s i b i l i t y i s that some of the c e l l s produce com-
plement i n the area of the graft ( I S ) . The effectiveness 
of the l y t i c action of antibody i s dependent on comple-
ment, and since the s i t e of formation of complement 
remains unknown, t h i s possible function of the immune 
c e l l s needs to be stressed. 
At t h i s stage neither the concept of delayed hyper-
s e n s i t i v i t y nor the r e a l i s a t i o n that the immune c e l l i s 
involved i n graft r e j e c t i o n increase the understanding 
of how the f i n a l immune state i s achieved. 
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Immune c e l l s have been studied i n simpler model 
systems and there i s evidence to suggest that the reac-
tion i s most intense where host c e l l s come into d i r e c t 
contact eith e r with antigen (see 120) or antibody ( 9 ) . 
This provides strong presumptive evidence f o r the p a r t i -
cipation of host c e l l s . Favour f i r s t showed the property 
of llympholysis', xvhen he found that tuberculin would 
cause the l y s i s of granulocytes and lymphocytes of sen-
s i t i s e d animals, providing complement was present (46). 
Many c e l l s of the r e t i c u l o e n d o t h e l i a l system are known 
to possess t h i s property (see 120). 
On the other hand, there i s evidence that where 
both the antigen and the antibody are e x t r a c e l l u l a r , 
l y s i s of cer t a i n c e l l s can occur; Middlebrook and Dubos 
have shown that red c e l l s w i l l adsorb antigen on t h e i r 
surfaces and that the c e l l s w i l l l y s e in the presence of 
the appropriate antibody (90). This has been confirmed 
on many occasions (2#). Recently, Amos has shown a simi-
l a r e f f e c t involving host h i s t i o c y t e s . Host h i s t i o c y t e s 
can adsorb or ingest tumour antigen and these c e l l s w i l l 
l y s e i f host a n t i tumour antibody i s added in v i t r o ( 9 ) . 
Thus many host c e l l s have the potential and are 
known to lyse e a s i l y . I t i s possible that t h i s effect 
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though e x t r a c e l l u l a r i s a major determinant of graft 
r e j e c t i o n ( 8 ) . The Ireac.fclxfTT' shown by Amos only occurred 
at a c r i t i c a l stage i n graft r e j e c t i o n i n the l o c a l area 
of the graft. 
Wissler and Flax have suggested that the antibody 
may protect the host c e l l (124) by damping down an a l l e r -
gic response. They have suggested that the antibody 
might a c t i v e l y neutralise the free antigen i n the area 
of the graft, so that the immune c e l l i s able to act d i -
r e c t l y on the graft c e l l . 
Antibody does act synergically with immune c e l l s i n 
vivo. Batchelor, Boyse and Gorer have shown t h i s e f f e c t 
experimentally, and have indicated that the eff e c t i s of 
major importance i n graft r e j e c t i o n (17). Although i n 
cer t a i n situations both antibody and.cells can tr a n s f e r 
immunity independently, they have shown that the effect 
can be f a r greater i f the antibody and c e l l s are injected 
simultaneously. Gorer does not attempt to explain syner-
gism, although he emphasises that the effect i s destroyed 
i f too much antibody i s transferred (55). I t would seem 
that i f the equilibrium between the immune c e l l and the 
antibody i s disturbed the regression of the tumour may 
be delayed or even aborted. I t i s possible that t h i s 
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i s the reason why passively transferred antibody can 
enhance the growth of a tumour in certain experimental 
situations (69). 
A l l these experimental systems have defined i n d i v i -
dual properties of the immune system. There i s evidence 
that antibody can have a direct e f f e c t on the graft c e l l , 
that antibody and host c e l l s can act synergically on the 
graft c e l l and that i t i s possible for the immune c e l l 
to cause the death of the graft c e l l by direct contact. 
A l l t h i s evidence i s fragmentary and the r e l a t i v e impor-
tance of these e f f e c t s i n any s p e c i f i c homograft s i t u a -
t ion i s not known. These e f f e c t s may r e f l e c t quite 
different mechanisms of homograft r e j e c t i o n . 
Studies on the a c t i v e l y immune animal suggest that 
different mechanisms may be involved. Hildemann and 
Walford have shown recently that where the genetic d i f -
ferences between graft and host were very s l i g h t , i t 
took several months f o r the homograft to be rejected. 
This chronic r e j e c t i o n e l i c i t e d quite a c h a r a c t e r i s t i c 
c e l l u l a r response (67). For a long time, Gorer has em-
phasised that the host c e l l u l a r response i s determined 
mainly by the nature of the graft (54). 
Lymphomas e l i c i t quite a c h a r a c t e r i s t i c c e l l u l a r 
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response. Gorer notes that i n t h i s Type 3 graft 
'that few host c e l l s entered the reaction i n the early 
stages, on the s i x t h day, there i s a very marked exuda-
tion reaction together with considerable c y t o l y s i s of 
the malignant c e l l s . This continues, but from about 
the ninth day onwards i s accompanied by h i s t i o c y t i c 
invasion. The h i s t i o c y t e s function largely as scaven-
gers ' Gorer considered that the lymphomas were 
p a r t i c u l a r l y vulnerable to antibody attack ( 54 ) . 
The present study has gathered considerable support 
f o r t h i s view. The r e j e c t i o n of the lymphomas followed 
Gorer's description c l o s e l y . I t was shown that antibody 
was produced i n the animal early, that the antibody 
could l y s e the c e l l s d i r e c t l y and that t h e o r e t i c a l l y , 
there was s u f f i c i e n t antibody i n the system to cause the 
death of a l l the graft c e l l s present. This study did 
not determine the extent of host c e l l p a r t icipation i n 
graft r e j e c t i o n and the precise role of antibody i n the 
active r e j e c t i o n of these grafts has s t i l l to be deter-
mined. The p a r t i c i p a t i o n of antibody i n the Type 1 and 
Type 2 grafts of Gorer i s even l e s s c e r t a i n . 
The importance of t h i s study i s that i t established 
that antibody i s able to dariiape certain graft c e l l s 
- 39 -
d i r e c t l y , and that t h i s effect i s dependent upon the 
presence of complement. Many other c e l l types are 
known to bind antibody, but u n t i l the l e v e l of humoral 
complement i n the t e s t system i s known and the c e l l s 
that produce complement are recognised, the f u l l e f f e c t 
of humoral antibody i n the homograft reaction w i l l not 
be known. 
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SUMMARY 
1. Antibody production appeared to be a character-
i s t i c feature of the homograft reaction i n the mouse. 
Iso-antibody was produced before there were v i s i b l e 
signs that the graft c e l l s were being destroyed. 
2. At the time of rejection, there was s u f f i c i e n t 
antibody in the animal to k i l l a l l the graft c e l l s pre-
sent. Many of the graft c e l l s were f u l l y s e n s i t i s e d 
with antibody during the r e j e c t i o n phase. 
3. The iso-antibody produced was d i r e c t l y cytotoxic 
to the leukotic graft c e l l s . This could be shown most 
c l e a r l y , i n vivo, by using diffusion chambers. Here, 
the antibody caused damage and considerable l y s i s of 
the graft c e l l s . 
4. L y s i s took place i n two w e l l defined stages. 
Antibody became bound to the graft c e l l s , but i n spite 
of t h i s , the c e l l s remained viable and multiplied i n the 
presence of the antibody. I f complement was added, the 
c e l l s were i r r e v e r s i b l y damaged and most of the c e l l s 
lysed immediately. 
5. Not a l l the graft c e l l s i n the chamber were 
destroyed. This appeared to be due to the low l e v e l s 
of complement in the chamber, rather than to v a r i a b i l i t y 
i n the s u s c e p t i b i l i t y of the individual c e l l s to humoral 
antibody. 
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TABLE 1. The incidence of antibody i n the serum and peritoneum 
during the a c t i v e r e j e c t i o n of tumour c e l l s from the 
p e r i t o n e a l s i t e . 
Over 1 x 1 0 tumour: 
c e l l s i n peritoneum L e s s than 1 x 1 0 ^ tumour c e l l s i n peritoneum 
F l u i d 
t e s t e d 
Antibody Antibody Not ? 
present absent t e s t e d 
Antibody -Antibody Not 
present absent t e s t e d 
Serum * 6 0 0 8 0 0 
P e r i t o n e a l 
F l u i d 
0 6 0 4 1 3 
* N u m b e r of- AniTvate Keshser 
TABLE 2. The d e t e c t i o n of c y t o t o x i c antibody by the 
standard c y t o t o x i c i t y t e s t . 
C o n t r o l tubes 
c e l l s mixed w i t h 
Experimental tubes 
c e l l s mixed w i t h 
antibody and complement 
Mammalian Comple- A n t i -
Ringer ment body 
d i l u t i o n s of antibody 
1/8 1/16 1/32 1/64 
9* 7 8 48 43 17 6 
Antibody Serum from a C3K animal i n j e c t e d w i t h L1210 
tumour e i g h t days e a r l i e r . 
C e l l s L1210 c e l l s , 500,000 i n 0.1 ml. of 
Mammalian Ringer. 
Complement Serugi from s e l e c t e d Guinea P i g s d i l u t e d 
66% w i t h Mammalian Ringer. 
* The % dead C e l ! L ^ - « eacn p&pu-lai-ion.. 
TABLE 3 D e t e c t i o n of c y t o t o x i c antibody 
M o d i f i c a t i o n A ; 
C o n t r o l tubes 
c e l l s mixed w i t h 
Experimental tubes 
c e l l s p r e s e n s i t i s e d 
with 3 vols,serum. 
Mammalian Comple- Antibody 
Ringer ment 3 volumes 
Complement added. 
Serum #1 8* 6 9 73 
1 " #2' 10 89 
• #3 7 14 
Normal C3H 6 
serum 
6 
Antibody Serum #1, #2 and #3 from C3H mice i n j e c t e d with 
L1210 tumour c e l l s seven days e a r l i e r . 
C e l l s Stock L1210 tumour cells,500,000 c e l l s i n 0.1 ml. 
Complement Guinea P i g serum d i l u t e d to 66% with Mammalian 
Ringer. 
* The percentage of dead c e l l s i n a count of " 
2 0 0 . c e l l s . 
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TABLE 4 The d e t e c t i o n of c y t o t o x i c antibody. 
M o d i f i c a t i o n B. 
Con t r o l tubes 
c e l l s mixed w i t h 
Experimental tubes 
c e l l s mixed w i t h 
antibody and complement 
liSammalian Couple- A n t i -
Ringer ment body 
d i l u t i o n s of antibody 
1/5 1/10 1/20 1/40 1/80 
< 1* 1 5 95 73 20 4 2 
Antibody Hyperimmune DBA1 a n t i DBA2 antibody. 
C e l l s Stock L1210 c e l l s . 
Complement Guinea P i g serum d i l u t e d 66% w i t h Mammalian Ringer. 
Stage 2 
1 C o n t r o l tubes 
c e l l s mixed w i t h 
Experimental tubes 
c e l l s mixed w i t h 
antibody and complement 
Miammalian Comple- Antibody 
Ringer ment 1/4 
d i l u t i o n s of antibody 
1/4 1/8 1/16 
Serum 5 22.5 0.5 65 52 36 
A s c i t e s 9.0 . 32 28 27 
Normal DBAjp 
serum 
6.0 24 22 25 
Antibody Serum and a s c i t e s from a pool of DEAl mice 
i n j e c t e d w i t h L1210 tumour 7 days e a r l i e r . 
C e l l s L1210 c e l l s p r e s e n s i t i s e d with DBA^anti DBA2 
antibody a t 1/20. 
Complement Guinea P i g serum d i l u t e d to 66% w i t h 
Mammalien Ringer. 
* The % dead c e l l s i n a count, of 200 c e l l s . 
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TABLE 5 A comparison of 1. The r e l a t i v e s u s c e p t i b i l i t y to 
c y t o t o x i c antibody of stock tumour c e l l s and tumour 
c e l l s t h a t have grown i n an incompatible host f o r 
f i v e days, 
2. The r e l a t i v e e f f i c i e n c y of two 
sources of complement i n the c y t o t o x i c i t y t e s t . 
C o n t r o l tubes 
C e l l s p r e s e n s i t i s e d w i t h 
1 vol onormal mouse serum. 
Experimental tubes 
C e l l s p r e s e n s i t i s e d w i t h 
1 vol.experimental.serum. 
C e l l s M.R. 
Comp] 
G.P.S, 
.ement 
[M.M.l 
added 
, M.M.2, M.M.3. Ct.R. 
Comple 
G.P.S, 
sment : 
, M.M.l 
idded 
, M.M.2, M.M.3. 
A ! 1.0* 2.0 1.5 2.5 3.5 5.0 8.0 95S5 84.5 100.0 
B 2.0 3.0 23.0 10.5 7.5 4.0 10.0 87.5 67.5 96.0 
Experimental 
serum 
C e l l s 
Complement 
M.R. 
* 
Serum from C3H animals i n j e c t e d w i t h QL1 tumour 
f i v e days e a r l i e r . 
A Stock QL1 tumour c e l l s . 
B QL1 c e l l s from the same C3H animals from 
which the serum was taken. 
G.P.S. Normal Guinea P i g serum d i l u t e d to 66^. 
M.M.l.2 and 3. Three samples of Human serum 
from M u l t i p l e Myeloma p a t i e n t s , d i l u t e d to.66$. 
Mammalian Ringer. 
The percentage of dead c e l l s i n a count of 
200 c e l l s . 
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TABLE 6 The s t a t e of s e n s i t i s a t i o n of the L1210 tumour 
populations during the r e j e c t i o n phase. 
Days a f t e r i n j e c t i o n of 
i n t o the peritoneum 
tumour 
4 5 6 7 8 
% populations 
showing evidence 
of s e n s i t i s a t i o n 
0 0 50 33 62 
Number of animal 
i n each sample 
s 6 8 16 18 8 
A population i s considered to show evidence of s e n s i t i s a t i o n 
i f there i s a 1.0$ i n c r e a s e i n death, when complement i s 
added to the c e l l s . 
Both Guinea P i g and M u l t i p l e Myeloma serum were used as 
sources of complement. These were s e l e c t e d . t o be f r e e from 
t o x i c i t y a g a i n s t stock tumour c e l l s . 
TABLE 7 The i n c i d e n c e of dead c e l l s i n L1210 tumour 
populations during the r e j e c t i o n phase. 
Days a f t e r i n j e c t i o n of tumour 
into peritoneum 
4 5 6 7 8 
% populations 
w i t h more than 
5% dead 
36 37 33 39 50 
10% dead 0 0 11 17 25 
Number of animal 
i n each sample 
s 6 8 18 18 8 
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TABLE 8 The d e t e c t i o n of c y t o t o x i c antibody i n the 
chamber f l u i d s . 
Experimental 
proceedure Antibody 
detected 
could 
damage * 
Number of 
c e l l s i n 
the chamber 
a t the t ime 
of sampling 
Number of-
i n j e c t i o n e 
of antibody 
volume of 
antibody 
i n j e c t e d 
time of 
sampling 
2 0. 2ml 24hrs. 6 >6.4xl0 
6 
2.3x10 
3 0.2ml 24 " >6.4x " 1.7 * " 
3 0.2ml 72 " >7.2* " f . 2 x » 
0 none - 1.6*10 5 4.9* " 
S t r e n g t h of the antibody i n j e c t e d * . 
6 
o.2ml would damage 1 9 x 1 0 Rumour c e l l s . 
0 . 6 " " " 5 7 x » " » 
*The a c t i v i t y of the chamber f l u i d s was, determined by 
the i n v i t r o c y t o t o x i c i t y t e s t , where heterologous 
complement was present i n excess ( .59).Thenumber of c e l l s 
i n each tube i s approximately 1 2 5 , 0 0 0 and since 0 . 0 2 5 ml. 
antibody of known d i l u t i o n i s added,a ' d e s t r u c t i v e index* 
can be determined. 
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TABLE 9 A comparison of the t h e o r e t i c a l c y t o t o x i c e f f e c t s 
of the antibody injected,based on the c y t o x i c i t y 
t e s t , w i t h the a c t u a l damage caused t o the t a r g e t 
p o p u l a t i o n s . 
T h e o r e t i c a l 
damage of 
A c t u a l damage 
the chamber c e l l s 
Approximate 
number of 
tumour c e l l s 
i n the chamber 
a t the time 
of i n j e c t i o n 
of antibody. 
Experiment T o t a l Chamber 
serum f l u i d 
L y s i s Damage T o t a l 
A 4.6* 0.46 1.3 0.3 1.6 0.7 - 1.9 
B >19.0 >1.9 1.0 0.25 1.25 0.4 - 1.9 
C >32.0 >3.2 2.0 0.1 2.1 0.7 - 2.5 
* Denotes the size of the p o p u l a t i o n a f f e c t e d by the 
antibody i n m i l l i o n s of c e l l s . 
The t h e o r e t i c a l a c t i v i t y of the serum and the chamber f l u i d 
was determined by means of the i n Y i t r o c y t o t o x i c i t y t e s t . 
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TABLE 10 A comparison of the r e l a t i v e s u s c e p t i b i l i t y t o 
antibody of a s e r i e s of tumour c e l l p o p u l a t i o n s . 
C o n t r o l tubes 
c e l l s mixed w i t h 
Experimental tubes 
c e l l s mixed w i t h 
antibody and complement 
lammalian Comple- Antibody 
Ringer ment 1/5 
d i l u t i o n s of antibody 
1/5 1/10 1/40 
C e l l s A 9* • 5 16 100 87 11 
" B 12 5 13 95 85 18 
" C 49 81 43 88 79 77 
Antibody DBAi a n t i D B A 2 thymoma. 
C e l l s A Stock DBAg a s c i t e s c e l l s . 
B DBAgthymoma c e l l s grown i n a chamber. 
C DBAg c e l l s grown i n a chamber t o which 
0.8ml. antibody was sodded. 
Complement Guimea Pig serum d i l u t e d t o 66% w i t h 
Mammalian Ringer. 
* The percentage dead c e l l s i n a. count of 
200 c e l l s . 
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TABLE 11 A comparison of the r e l a t i v e s u s c e p t i b i t y of 
stock and 'passaged' D B A 2 thymoma c e l l s t o 
c y t o t o x i c antibody. ; 
Co n t r o l tubes 
c e l l s mixed w i t h 
Experimental tubes 
c e l l s mixed w i t h 
antibody and complement 
Mammalian Comple- Antibody 
Ringer ment 1/5 
d i l u t i o n s of antibody 
1/5 1/10 1/20 J/40 
S e l l s A 8* 1 0 7 9 5 98 98 95 
" B 1 1 3 32. 70 64 46 
Antibody DBAi a n t i B B A 2 thymoma. 
C e l l s A Stock DBA2 a s c i t e s c e l l s . 
B 'Passaged' c e l l s . This l i n e was derived 
from the residuaL c e l l s of a few chambers a f t e r 
treatment w i t h antibody. The l i n e had been maintained 
by passaging the c e l l s through weakly immunised 
DBA-L animals f o r f i v e generations. 
Complement Guinea P i g serum d i l u t e d to 66% w i t h 
Mammalian Ringer. 
* The percentage dead c e l l s i n a count of 
200 c e l l s . 
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GRAPH 1 The t i m i n g of the appearance of haemagglutinins 
i n r e l a t i o n to tumour growth. 
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-x Tumour p o p u l a t i o n 
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Each p o i n t represents the average f o r t h a t day. 
Size of samples 
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Days 
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and serums 
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3 c 
£ 
«• 
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GRAPH 2 To show the l e v e l of antibody i n the serum and 
p e r i t o n e a l f l u i d of i n d i v i d u a l DBA-^  animals, 
d u r i n g the r e j e c t i o n of 20 m i l l i o n L121Q c e l l s . 
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/ 64 / 0 
/ r 32 / / 
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y 8 
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The l i n e s are drawn from the average value f o r each day. 
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GRAPH 2a To show the l e v e l of antibody i n the serum and 
p e r i t o n e a l f l u i d of i n d i v i d u a l C3H animals, 
d u r i n g the r e j e c t i o n of 20 m i l l i o n L121Q c e l l s . 
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The l i n e s are drawn from the average value f o r each day. 
- 116 -
GRAPH 5 The growth curves of three a s c i t e s tumours 
growing i n d i f f u s i o n chambers 
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GRAPH 4 and 5 D e t a i l s of the growth curve of 
DBAp thymoma 
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G R A F H 6 T h e e f f e c t of a s i n g l e i n j e c t i o n of 
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* Animals i n j e c t e d w i t h 0.1ml. normal 
mouse serum. 
V Time of i n j e c t i o n . 
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A comparison of the e f f e c t of d i f f e r e n t volume 
of antibody on DBA9 thymoma po p u l a t i o n s . 
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GRAPH 8 Antibody i n j e c t e d on two successive days 
to a growing DBA?, thymoma p o p u l a t i o n 
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antibody on Day 3. 
©• © Treated w i t h 0.3ml. DBA^ a n t i D B A 2 
antibody on Day 3 and Day 4. 
* Time of i n j e c t i o n of antibody. 
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GRAPH 9 The e f f e c t of i n j e c t i n g antibody on f o u r successive 
days. 
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GRAPH 10 A comparison of the antibody s e n s i t i v i t y of two 
D B A 2 thymoma l i n e s , the stock l i n e and a l i n e 
p o s s i b l y c o n t a i n i n g antibody r e s i s t e n t c e l l s . 
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GRAPHS 11,12,13. The e f f e c t of adding e i t h e r Guinea Pig Serum 
or Normal Mouse Serum to populations p r e v i o u s l y 
t r e a t e d w i t h antibody. 
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Graph 14 A d e t a i l e d study of the e f f e c t s of antibody and 
complement on a ne o p l a s t i c p o p u l a t i o n . 
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GRAPH 15 The e f f e c t of m u l t i p l e i n j e c t i o n s of mouse 
complement on s e n s i t i s e d neoplastic populations 
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GRAPH 16 
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The l e v e l s of complement i n the serum, p e r i t o n e a l 
f l u i d and chamber f l u i d of normal mice and mice 
i n j e c t e d w i t h normal mouse serum by the i n t r a -
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A l l the f l u i d s were d i l u t e d 1/2. 
The red c e l l suspension was standardised so t h a t 100% 
haemolysis would give an O p t i c a l Density 
56 on the Coleman spectrophotometer. 
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